<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">868401</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2022.868401</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Functional Regulation of K<sub>ATP</sub> Channels and Mutant Insight Into Clinical Therapeutic Strategies in Cardiovascular Diseases</article-title>
<alt-title alt-title-type="left-running-head">Wang et al.</alt-title>
<alt-title alt-title-type="right-running-head">K<sub>ATP</sub> Channels and Mutant</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Zhicheng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1462039/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bian</surname>
<given-names>Weikang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1445914/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yan</surname>
<given-names>Yufeng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Dai-Min</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1189944/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Cardiology</institution>, <institution>Nanjing First Hospital</institution>, <institution>Nanjing Medical University</institution>, <addr-line>Nanjing</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Cardiology</institution>, <institution>Sir Run Run Hospital</institution>, <institution>Nanjing Medical University</institution>, <addr-line>Nanjing</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/10438/overview">Ismail Laher</ext-link>, University of British Columbia, Canada</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1526666/overview">Khaled S. Abd-Elrahman</ext-link>, University of Ottawa, Canada</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/425462/overview">Masayo Koide</ext-link>, University of Vermont, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/784155/overview">Michael Christian Puljung</ext-link>, Trinity College, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/948172/overview">Pei-Chun Chen</ext-link>, National Cheng Kung University, Taiwan</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Dai-Min Zhang, <email>daiminzh@126.com</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Cardiovascular and Smooth Muscle Pharmacology, a section of the journal Frontiers in Pharmacology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>06</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>868401</elocation-id>
<history>
<date date-type="received">
<day>02</day>
<month>02</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>06</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Wang, Bian, Yan and Zhang.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Wang, Bian, Yan and Zhang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>ATP-sensitive potassium channels (K<sub>ATP</sub> channels) play pivotal roles in excitable cells and link cellular metabolism with membrane excitability. The action potential converts electricity into dynamics by ion channel-mediated ion exchange to generate systole, involved in every heartbeat. Activation of the K<sub>ATP</sub> channel repolarizes the membrane potential and decreases early afterdepolarization (EAD)-mediated arrhythmias. K<sub>ATP</sub> channels in cardiomyocytes have less function under physiological conditions but they open during severe and prolonged anoxia due to a reduced ATP/ADP ratio, lessening cellular excitability and thus preventing action potential generation and cell contraction. Small active molecules activate and enhance the opening of the K<sub>ATP</sub> channel, which induces the repolarization of the membrane and decreases the occurrence of malignant arrhythmia. Accumulated evidence indicates that mutation of K<sub>ATP</sub> channels deteriorates the regulatory roles in mutation-related diseases. However, patients with mutations in K<sub>ATP</sub> channels still have no efficient treatment. Hence, in this study, we describe the role of K<sub>ATP</sub> channels and subunits in angiocardiopathy, summarize the mutations of the K<sub>ATP</sub> channels and the functional regulation of small active molecules in K<sub>ATP</sub> channels, elucidate the potential mechanisms of mutant K<sub>ATP</sub> channels and provide insight into clinical therapeutic strategies.</p>
</abstract>
<kwd-group>
<kwd>K<sub>ATP</sub> channels</kwd>
<kwd>mitoK<sub>ATP</sub> channels</kwd>
<kwd>myocardial ischemia</kwd>
<kwd>channelopathy</kwd>
<kwd>small active molecules</kwd>
<kwd>mutation</kwd>
</kwd-group>
<contract-num rid="cn002">BE2018611</contract-num>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Jiangsu Provincial Key Research and Development Program<named-content content-type="fundref-id">10.13039/501100013058</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>The aging of the population and improved survival after acute myocardial infarction have resulted in high morbidity and mortality, a poor clinical prognosis and high expenses due to heart failure (HF) (<xref ref-type="bibr" rid="B89">Savarese et al., 2022</xref>). The prevalence of HF is predicted to increase by 46% from 2012 to 2030. After several years of therapeutic exploration, the prognosis of HF remains poor, with a 5-years mortality of &#x2248;40%&#x2013;50%, and the projections suggest that the total costs for HF in 2030 will be close to $38.99 billion in the United States (<xref ref-type="bibr" rid="B48">Kaneko et al., 2021</xref>; <xref ref-type="bibr" rid="B116">Yu et al., 2021</xref>; <xref ref-type="bibr" rid="B89">Savarese et al., 2022</xref>). Sudden cardiac death (SCD) is the leading cause of death in HF, and malignant arrhythmia is regarded as the overriding risk within SCD (<xref ref-type="bibr" rid="B1">Akhtar et al., 2021</xref>; <xref ref-type="bibr" rid="B35">Grune et al., 2021</xref>; <xref ref-type="bibr" rid="B73">Mulder et al., 2021</xref>). HF involves numerous physiological and pathological processes, among which calcium (Ca<sup>2&#x2b;</sup>) overload is a typical representative. Ca<sup>2&#x2b;</sup> overload destroys membranes, organelles and DNA, leading to structural and functional disruption of cells and tissues, eventually promoting cardiomyopathy, ventricular fibrillation and sudden death (<xref ref-type="bibr" rid="B114">Yang et al., 2021</xref>).</p>
<p>ATP-sensitive potassium channels (K<sub>ATP</sub> channels) were first discovered in cardiac muscle in 1983 by Noma (<xref ref-type="bibr" rid="B74">Noma, 1983</xref>) and were successively found in skeletal muscle, the digestive system, urinary system, integumentary system, reproductive system, and central nervous system (<xref ref-type="bibr" rid="B43">Huang et al., 2019</xref>; <xref ref-type="bibr" rid="B123">Zhao et al., 2020</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref>). Activating K<sub>ATP</sub> channels shorten the action potential duration, reduce intracellular Ca<sup>2&#x2b;</sup> entry to suppress calcium overload, inhibit contractility, and prevent arrhythmias and cardiac insufficiency caused by calcium overload; however, completely opening K<sub>ATP</sub> channels in the heart may result in complete cessation of cardiac electrical activity and contractile failure (<xref ref-type="bibr" rid="B43">Huang et al., 2019</xref>). Hence, K<sub>ATP</sub> channels play an irreplaceable role in HF, whether from myocardial ischemia or arrhythmia.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>The Structure of the K<sub>ATP</sub> Channel. <bold>(A)</bold>. K<sub>ATP</sub> channels are comprised of four sulfonylurea receptors (SURx) and four K<sup>&#x2b;</sup> inward rectifiers (Kir6. x) that assemble to form hetero-octameric protein complexes. The green and pink sections on the left represent the side view of the Kir6. x subunit, and the gold and purple sections on the right represent the side view of the SURx subunit. FASTA comes from NCBI, designed by <ext-link ext-link-type="uri" xlink:href="http://www.swissmodel.com/">www.swissmodel.com</ext-link>, Image designed by Swiss-Pdbviewer software. <bold>(B)</bold>. The pore-forming subunit Kir6. x (Kir6.1 and Kir6.2) has intracellular N- and C-termini and two transmembrane segments M1 and M2, encoded by KCNJ8 and KCNJ11, respectively. The modulatory subunit SURX (SUR1, SUR2A, SUR2B) consists of three groups of transmembrane domains (TMD0, TMD1 and TMD2) and extracellular N- and intracellular C-termini, encoded by ABCC8 and ABCC9. There are two intracellular nucleotide binding folds (NBD1 and NBD2) within the SUR subunit. ABCC8 and KCNJ11 are adjacent to each other on chromosome 11p15.1, with ABCC9 and KCNJ8 on chromosome 12P12.1.</p>
</caption>
<graphic xlink:href="fphar-13-868401-g001.tif"/>
</fig>
<p>K<sub>ATP</sub> channels are widely distributed in various organs, but the assembly of their subunits varies depending upon the tissue and they may confer different functional and pharmacological properties depending on which subunits are present (<xref ref-type="bibr" rid="B61">Li et al., 2021</xref>; <xref ref-type="bibr" rid="B100">Stewart and Turner, 2021</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). K<sub>ATP</sub> channels are comprised of four sulfonylurea receptors (SURx) and four K<sup>&#x2b;</sup> inward rectifiers (Kir6. x) that assemble to form hetero-octameric protein complexes. The pore-forming subunit Kir6. x (Kir6.1 and Kir6.2) has intracellular N- and C-termini and two transmembrane segments M1 and M2, encoded by KCNJ8 and KCNJ11, respectively. The modulatory subunit SURx (SUR1, SUR2A, SUR2B) consists of three groups of transmembrane domains (TMD0, TMD1 and TMD2) and extracellular N- and intracellular C-termini, encoded by ABCC8 and ABCC9. There are two intracellular nucleotide binding folds (NBD1 and NBD2) within the SUR subunit. ABCC8 and KCNJ11 are adjacent to each other on chromosome 11p15.1, with ABCC9 and KCNJ8 on chromosome 12P12.1.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Distribution of K<sub>ATP</sub> channels.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">System</th>
<th align="center">Organ/Tissue/Cell</th>
<th align="center">Subunit Types</th>
<th align="center">Disease Contributory</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="5" align="left">Circulatory System</td>
<td align="left">Atrium</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Ventricle</td>
<td align="left">Kir6.2/SUR2B, Kir6.2/SUR1 (<xref ref-type="bibr" rid="B120">Zhang et al., 2013</xref>)</td>
<td align="left">Atrial Fibrillation, Hypertension</td>
</tr>
<tr>
<td align="left">Vascular smooth muscle</td>
<td align="left">Kir6.2/SUR2A (<xref ref-type="bibr" rid="B113">Yang et al., 2020b</xref>)</td>
<td align="left">Dilated Cardiomyopathy, Myocardial Ischemia, Endothelium</td>
</tr>
<tr>
<td align="left">Endothelial cell</td>
<td align="left">Kir6.1/SUR2B (<xref ref-type="bibr" rid="B119">Zhang et al., 2021a</xref>)</td>
<td align="left">Dysfunction, Vasculature Atherosclerosis (<xref ref-type="bibr" rid="B120">Zhang et al., 2013</xref>; <xref ref-type="bibr" rid="B109">Wang et al., 2019b</xref>; <xref ref-type="bibr" rid="B113">Yang et al., 2020b</xref>; <xref ref-type="bibr" rid="B119">Zhang et al., 2021a</xref>)</td>
</tr>
<tr>
<td align="left">Capillary endothelial cell</td>
<td align="left">Kir6.1/Kir6.2/SUR2B (<xref ref-type="bibr" rid="B109">Wang et al., 2019b</xref>)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Respiratory System</td>
<td align="left">Alveolar epithelial cells</td>
<td align="left">Kir6.1/SUR2B (<xref ref-type="bibr" rid="B56">Leroy et al., 2006</xref>)</td>
<td align="left">Pulmonary Hypertension (<xref ref-type="bibr" rid="B56">Leroy et al., 2006</xref>; <xref ref-type="bibr" rid="B83">Rieg et al., 2020</xref>)</td>
</tr>
<tr>
<td rowspan="3" align="left">Digestive System</td>
<td align="left">Mesenteri artery</td>
<td align="left">Kir6.1 (<xref ref-type="bibr" rid="B60">Li et al., 2020b</xref>; <xref ref-type="bibr" rid="B46">Jin et al., 2020</xref>)</td>
<td align="left">Regulation of Blood Pressure, Excessive Atherosclerotic (<xref ref-type="bibr" rid="B60">Li et al., 2020b</xref>)</td>
</tr>
<tr>
<td align="left">Gastric smooth muscle</td>
<td align="left">Kir6.1/SUR2B (<xref ref-type="bibr" rid="B94">Sim et al., 2002</xref>)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Liver</td>
<td align="left">Kir6.1/Kir6.2/SUR1/SUR2A/SUR2B (<xref ref-type="bibr" rid="B125">Zhou et al., 2019b</xref>)</td>
<td align="left"/>
</tr>
</tbody>
</table>
</table-wrap>
<p>Cardiac K<sub>ATP</sub> channels provide cardioprotection against ischemia/reperfusion injury; in contrast, overexpressed cardiac K<sub>ATP</sub> channels have proarrhythmic effects, which associates them with profound value for clinical applications and exploration. There are three subtypes of K<sub>ATP</sub> channels found within the cardiovascular system: two widely accepted channels, mitoK<sub>ATP</sub> and sarcolemma K<sub>ATP</sub>, and a controversial K<sub>ATP</sub> channel, plasma membrane K<sub>ATP</sub> (<xref ref-type="bibr" rid="B44">Iguchi et al., 2019</xref>; <xref ref-type="bibr" rid="B78">Pertiwi et al., 2019</xref>; <xref ref-type="bibr" rid="B3">Aziz et al., 2020</xref>; <xref ref-type="bibr" rid="B45">Jiang et al., 2021</xref>)<sub>.</sub> Different cardiac K<sub>ATP</sub> channels play different roles in the cardiovascular system, which will be explained here. Recent evidence has shown that several refractory diseases are closely related to mutations in K<sub>ATP</sub> channel subunits. Disease-related clinical symptoms and high medical costs will burden the patient, the family, and society. Most encouraging, some K<sub>ATP</sub> channel activators and antagonists have shown good results for treating K<sub>ATP</sub> channel subunit mutation-related diseases, such as Cant&#xfa; syndrome, congenital hyperinsulinism (CHI), neonatal diabetes mellitus (NDM), developmental delay epilepsy and neonatal diabetes (DEND) and ABCC9-related intellectual disability myopathy Syndrome (AIMS) (<xref ref-type="bibr" rid="B24">Demirbilek et al., 2019</xref>; <xref ref-type="bibr" rid="B70">Martin et al., 2020</xref>; <xref ref-type="bibr" rid="B71">McClenaghan et al., 2020</xref>).</p>
<p>In this review, we focus on the regulatory mechanism of K<sub>ATP</sub> channels during angiocardiopathy and provide insights into how mutations in K<sub>ATP</sub> channelopathies lead to some incurable diseases. Furthermore, we will explore the therapeutic strategy of targeting K<sub>ATP</sub> channel drugs in clinical practice.</p>
</sec>
<sec id="s2">
<title>K<sub>ATP</sub> Channels in Cardiovascular Diseases</title>
<sec id="s2-1">
<title>Mitochondrial ATP-Sensitive Potassium Channels (mitoK<sub>ATP</sub> Channels)</title>
<p>As an independent factor associated with high mortality, acute myocardial infarction is an irreversible process characterized by glycogen depletion, margination of nuclear chromatin, mitochondrial swelling and sarcolemmal breaks. Myocardial infarct size and the duration of ischemia are the main determinants of the prognosis (<xref ref-type="bibr" rid="B41">Heusch, 2020</xref>). Rapidly restoring blood flow is the key to successful salvage of ischemic myocardium; however, reperfusion not only salvages ischemic myocardium from infarction but also induces an increased risk of additional complications and further cardiomyocyte death, a process called myocardial ischemia reperfusion injury (MIRI) (<xref ref-type="bibr" rid="B34">Griffiths et al., 2021</xref>). In myocardial ischemia, the mitochondrial matrix is damaged and extensively broken, and it dissolves the mitochondrial crest, ruptures and vacuolates the mitochondrial membrane, significantly decreases glycogen granules, increases intracellular Ca<sup>2&#x2b;</sup>, diminishes ATP production, and induces myocardial cell apoptosis (<xref ref-type="bibr" rid="B75">Paggio et al., 2019</xref>; <xref ref-type="bibr" rid="B6">Basalay et al., 2020</xref>; <xref ref-type="bibr" rid="B110">Wang et al., 2020</xref>; <xref ref-type="bibr" rid="B4">Bai et al., 2021</xref>; <xref ref-type="bibr" rid="B108">Wang et al., 2021</xref>). A novel autologous mitochondrial transplantation therapy, in which respiration-competent mitochondria are isolated from autologous nonischemic tissue and transplanted into ischemic myocardium, improves the contractile function and tissue viability of the injured myocardium, proving that mitochondrial injury is the main pathogenesis of MIRI (<xref ref-type="bibr" rid="B92">Shin et al., 2019</xref>).</p>
<p>mitoK<sub>ATP</sub> channels are involved in a series of physiological and pathophysiological changes to mitigate cardiomyocyte injury and apoptosis. mitoK<sub>ATP</sub> channels have been described as being located in the inner mitochondrial membrane and they have protective properties for ischemic myocardium; moreover, their existence has been the subject of heated debate (<xref ref-type="bibr" rid="B7">Bezerra Pal&#xe1;cio et al., 2021</xref>). Recently, the molecular composition of mitoK<sub>ATP</sub> was shown by Paggio et al., and they are comprised of pore-forming (MITOK, encoded by the CCDC51 gene (NCBI ID 79714)) and regulatory (MITOSUR, tissue expression correlates with ABCB8) subunits (<xref ref-type="bibr" rid="B75">Paggio et al., 2019</xref>) (<xref ref-type="fig" rid="F2">Figure 2</xref>). The opening of mitoK<sub>ATP</sub> channels promotes mitochondrial K<sup>&#x2b;</sup> inward flow into the deeply negative polarized matrix (mitochondrial membrane potential (<italic>&#x3a8;</italic>
<sub>m</sub>)), decreases the transmembrane potential discrepancy, depolarizes the <italic>&#x3a8;</italic>
<sub>m</sub>, reduces Ca<sup>2&#x2b;</sup> inward flow dynamics, inhibits Ca<sup>2&#x2b;</sup> inward flow, and prevents mitochondrial calcium overload, leading to mitochondrial relaxation, enhanced fatty acid oxidation, oxidative phosphorylation, respiratory function, and ATP production, thus improving myocardial cell survival (<xref ref-type="bibr" rid="B88">Sakamoto and Kurokawa, 2019</xref>; <xref ref-type="bibr" rid="B45">Jiang et al., 2021</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>The role of mitoK<sub>ATP</sub> in myocardial ischemia and the regulation of the signaling pathways involved. <bold>(A)</bold>. Mitochondrial injury and mitoK<sub>ATP</sub> play a role in cardiac protection during the process of MIRI; MIRI increased Bax expression and decreased BCL<sub>2</sub> expression, triggering a cascade involving increased NO production and leading to the superficial formation of ONOO<sup>&#x2212;</sup> with increased production of ROS. Activation of mitoK<sub>ATP</sub> stimulates the anti-inflammatory and antioxidant effects of NO on ischemic myocardium by inhibiting the overproduction of ROS. Ischemic postadaptation activates protein kinase C and the reperfusion injury salvage kinase pathway through the intracellular concentration of adenosine and NO, and it acts on the mitoK<sub>ATP</sub> channel to protect the myocardium; activation of the mitoK<sub>ATP</sub> channel leads to cell hyperpolarization, resulting in reduced Ca<sup>2&#x2b;</sup> entry, and a reduced driving force of mitochondrial calcium uptake, prevent Ca<sup>2&#x2b;</sup> accumulation in the matrix and MPTP formation. The MPTP is the escape pore of ROS, Cyt C, Ca<sup>2&#x2b;</sup> and other signaling molecules. CF indicates cardiac fibroblasts; MF, myofibroblasts; MIRI, myocardial ischaemia reperfusion injury; and ONOO<sup>&#x2212;</sup>, peroxynitrite. <bold>(B)</bold>. The structure of MPTP; F1Fo ATP synthase: The Fo subunit consists of a, e, f, g and A6 L, the F1 component consists of &#x3b1; and <italic>&#xdf;</italic> subunits, labeled in bottle green and yellow, respectively, and the &#x3b3;, &#x3b5; subunits. The F1 peripheral stalk is comprised of subunits b, d, F6, and OSCP. The C cyclic subunit, ANT and PiC are overlaid by IMM; the dotted line represents the MPTP signal molecule outflow position. OSCP indicates oligomycin sensitivity conferring protein; IMM, inner mitochondrial membrane; ANT, adenine nucleotide translocase; and PiC, phosphate carrier. <bold>(C)</bold>. mitoK<sub>ATP</sub> channels prevent transdifferentiation of CF to MF to reduce MF maturation. Testosterone (10&#xa0;&#x3bc;M) increases the opening probability of mitoK<sub>ATP</sub> channels, PHC regulates the mitochondrial K<sub>ATP</sub> channel, Akt/GSK-3&#x3b2;, and Akt/mTOR signaling pathways, GST depends on protein-kinase C and mitoK<sub>ATP</sub> channel pathway activation by some typical pathways such as PI3K/Akt and NO synthases, and plays roles in cardioprotection. Uridine attenuates myocardial injury and oxidative stress by activating the mitoK<sub>ATP</sub> channel to reduce excessive ROS production and prevent calcium overload. PHC indicates penehyclidine hydrochloride; GST, genistein.</p>
</caption>
<graphic xlink:href="fphar-13-868401-g002.tif"/>
</fig>
<p>During the process of MIRI, the activation of mitochondrial K<sub>ATP</sub> channels depolarizes the mitochondrial membrane, reduces the driving force of mitochondrial calcium uptake, and prevents Ca<sup>2&#x2b;</sup> accumulation in the mitochondrial matrix, thus preventing the formation of the mitochondrial permeability transition pore (MPTP) (<xref ref-type="bibr" rid="B104">Testai et al., 2021</xref>). Currently, the main components of MPTP are as follows: adenine nucleotide translocator (ANT) and mitochondrial phosphate carrier (PiC) on the inner mitochondrial membrane (IMM), mammalian F1Fo(F)-ATP synthase (the Fo subunit consists of a, e, f, g and A6 L; the F1 subunit <italic>&#x3b1;</italic>, <italic>&#x3b2;</italic>, and the <italic>&#x3b5;</italic> and <italic>&#x3b3;</italic> subunits needed for ATP synthase dimer formation, the peripheral stem consists of b, d, and the F6 subunit and oligomycin sensitivity conferring protein (OSCP)) (<xref ref-type="bibr" rid="B50">Kent et al., 2021</xref>) (<xref ref-type="fig" rid="F2">Figure 2</xref>). MPTP is the point at which reactive oxygen species (ROS), Ca<sup>2&#x2b;</sup>, cytochrome C (Cyt C), and other small molecule modulators escape from the mitochondrial matrix, and its opening leads to the loss of oxidative phosphorylation capacity as well as the release of pro-death mitochondrial proteins (mitochondrial swelling and membrane rupture), increased Bax expression and decreased Bcl<sub>2</sub> expression, ultimately activating the apoptotic cascade in the mitochondria in ischemia&#x2013;reperfusion heart tissues (<xref ref-type="bibr" rid="B45">Jiang et al., 2021</xref>; <xref ref-type="bibr" rid="B50">Kent et al., 2021</xref>; <xref ref-type="bibr" rid="B77">Pereira and Kowaltowski, 2021</xref>). Mitochondrial ROS spreading from the electron transport chain damages the mitochondrial DNA, which can cause mitochondrial dysfunction and affect nuclear gene expression, ion handling, and mitochondrial metabolism, finally causing the activation of an inflammatory response, apoptotic signaling, and endoplasmic reticulum stress in the cardiovascular system (<xref ref-type="bibr" rid="B11">Bou-Teen et al., 2021</xref>). Indeed, MIRI triggers a cascade involving increased NO production (NO function; anti-inflammatory and antioxidant effects) and leads to the superfluous formation of peroxynitrite (ONOO<sup>&#x2212;</sup>) with increased production of ROS, which mediates the pernicious impact of NO (<xref ref-type="bibr" rid="B64">Liu et al., 2021a</xref>). The activation of mitoK<sub>ATP</sub> during ischemia plays a role in the cardioprotective function by inhibiting the overproduction of ROS and stimulating the NO effects on anti-inflammatory and antioxidant activities in the ischemic myocardium (<xref ref-type="bibr" rid="B64">Liu et al., 2021a</xref>; <xref ref-type="bibr" rid="B82">Rameshrad et al., 2021</xref>). Ischemic postconditioning activates protein kinase C and reperfusion injury salvage kinase pathways through modulating the intracellular concentrations of adenosine and NO, ultimately acting on the mitoK<sub>ATP</sub> pathway to protect the myocardium (<xref ref-type="bibr" rid="B59">Li et al., 2020a</xref>).</p>
<p>mitoK<sub>ATP</sub> channels also affect other cardiac components. Within rat cardiac fibroblasts (CFs), mitoK<sub>ATP</sub> channels prevent the transdifferentiation of CFs to myofibroblasts (MFs) to reduce MF maturation and antagonize cardiac pathological remodeling following simulated ischemia-reperfusion injury (<xref ref-type="bibr" rid="B100">Stewart and Turner, 2021</xref>). ROMK (a kidney mRNA detectable in the thick ascending limb and the distal nephron) participates in K<sup>&#x2b;</sup> reabsorption and secretion. An experiment performed by Irina B. Krylova et al. implicated ROMK in Ca<sup>2&#x2b;</sup>-induced MPTP opening but did not play a role in mitoK<sub>ATP</sub> activity in the mouse heart (<xref ref-type="bibr" rid="B76">Papanicolaou et al., 2020</xref>). Electrophysiological analysis revealed that 10&#xa0;&#x3bc;M testosterone increased the open probability of mitoK<sub>ATP</sub> channels, which offered cytoprotection against MIRI (<xref ref-type="bibr" rid="B88">Sakamoto and Kurokawa, 2019</xref>).</p>
<p>The recently discovered signal-regulated pathways involved in mitoK<sub>ATP</sub> channels are as follows. Penehyclidine hydrochloride (PHC) preconditioning plays a cardioprotective role by regulating the mitochondrial K<sub>ATP</sub> channel and Akt/GSK-3&#x3b2; and Akt/mTOR signaling pathways (<xref ref-type="bibr" rid="B127">Zi et al., 2020</xref>). Uridine attenuates myocardial injury and oxidative stress in MIRI, which may be mediated by activation of the mitoK<sub>ATP</sub> channel, achieved by reducing excessive ROS production and preventing the appearance of calcium overload (<xref ref-type="bibr" rid="B53">Krylova et al., 2021</xref>). GST (genistein, a phytoestrogen) provides a cardioprotective function that depends on protein kinase C and activates mitoK<sub>ATP</sub> channels via a typical pathway, such as PI3K/Akt and NO synthases (<xref ref-type="bibr" rid="B17">Colareda et al., 2020</xref>).</p>
</sec>
<sec id="s2-2">
<title>Sarcolemma ATP-Sensitive Potassium Channels</title>
<p>Early evidence indicated that sarcolemma ATP-sensitive potassium (sarcK<sub>ATP</sub>) channels play a crucial role in ischemic preconditioning and myocardial resistance to ischemia, which close during general conditions and open in response to increased [ADP]/[ATP], linking membrane excitability to the balance of ATP production and shortening action potential (AP) duration (APD) via the efflux of K<sup>&#x2b;</sup> (<xref ref-type="bibr" rid="B31">Garrott et al., 2017</xref>; <xref ref-type="bibr" rid="B101">Sudhir et al., 2020</xref>). SarcK<sub>ATP</sub> channels improve adaptation to physical stress and profoundly alter membrane excitability and other membrane potential-related functions, such as Ca<sup>2&#x2b;</sup> overload, thus helping to maintain cellular homeostasis during cardiac challenge (i.v. adenosine) (<xref ref-type="bibr" rid="B121">Zhang et al., 2016</xref>). The partial opening of sarcK<sub>ATP</sub> channels plays a crucial role in the regional depolarization of &#x3a8;m, which can transform cellular electrical excitability and increase the propensity for reentry arrhythmogenesis (<xref ref-type="bibr" rid="B98">Solhjoo and O&#x27;Rourke, 2015</xref>). An unstable or oscillating &#x3a8;m can expose cardiomyocytes to ROS or result in glutathione depletion, activate sarcK<sub>ATP</sub> channels and abate the cellular ATP/ADP ratio, which has been deemed to be a dominant factor in arrhythmogenesis during MIRI (<xref ref-type="bibr" rid="B98">Solhjoo and O&#x27;Rourke, 2015</xref>).</p>
<p>Increased activation of the sarcK<sub>ATP</sub> channel (a role in cardioprotection) does not participate in the protection provided by ordinary cardioprotective stimulation<sub>.</sub> sarcK<sub>ATP</sub> opening actually occurs later during metabolic inhibition (after cardioprotection), cardioprotective stimuli prolong normal mitochondrial function during ischemia, and the delay in the opening of sarcK<sub>ATP</sub> channels is a consequence of the continuation of ATP production, so sarcK<sub>ATP</sub> channel opening is the last defense of cardiomyocytes to preserve ATP and limit the Ca<sup>2&#x2b;</sup> overload during ischemia (<xref ref-type="bibr" rid="B12">Brennan et al., 2015</xref>). The density of sarcK<sub>ATP</sub> channels under physiological conditions plays a significant role in cardioprotection; however, certain pathophysiologic circumstances give rise to a declining density of sarcK<sub>ATP</sub> channels, including hyperinsulinemia and cardiac ischemia (<xref ref-type="bibr" rid="B112">Yang et al., 2018</xref>). The lower basal expression level of sarcK<sub>ATP</sub> channels in hESCs (human embryonic stem cells)-VCMs (ventricular cardiomyocytes) (&#x223c;1/8 of adults) means they were partially activated and sufficient to cause APD shortening and accelerate AP firing; when fully activated, sarcK<sub>ATP</sub> channels silenced automaticity without compromising intrinsic cellular excitability (<xref ref-type="bibr" rid="B51">Keung et al., 2016</xref>).</p>
<p>Studies on the cardiac sarcK<sub>ATP</sub> channel regulatory subunit SUR2A/SUR2B are ongoing. The activation of <italic>&#xdf;</italic>
<sub>1</sub>-adrenoceptors upregulates SUR2B/Kir6.2, in which SUR2B physically associates with Kir6.2 to act as a regulatory subunit in sarcK<sub>ATP</sub> channels to offer cardioprotection (<xref ref-type="bibr" rid="B47">Jovanovic et al., 2016</xref>). With an increasing number of sarcK<sub>ATP</sub> channels, increased expression of SUR2A regulates cardiac physiology and improves the adaptation to physical stress by shortening the action potential and improving cardiac Ca<sup>2&#x2b;</sup> homeostasis (<xref ref-type="bibr" rid="B121">Zhang et al., 2016</xref>).</p>
<p>The recently discovered signal-regulated pathways and regulatory proteins involved in sarcK<sub>ATP</sub> channels are as follows. Eps15 homology domain-containing protein (EHD)-2 affects the sarcK<sub>ATP</sub> channel by stabilizing sarcK<sub>ATP</sub> channel-containing caveolar structures to increase its surface density, which results in a reduced rate of endocytosis. Pathophysiologically, EHD-2 mutant-activated cardiomyocytes may be cardioprotective against ischemic damage (<xref ref-type="bibr" rid="B112">Yang et al., 2018</xref>). In rat cardiomyocytes, the sarcK<sub>ATP</sub> channel exerts a cardioprotective effect against lipopolysaccharide (LPS)-induced apoptosis and it is mediated by mitochondrial Ca<sup>2&#x2b;</sup> (<xref ref-type="bibr" rid="B121">Zhang et al., 2016</xref>). The cardioprotective effect of BNP is related to sarcK<sub>ATP</sub> channel opening. Additionally, the cardioprotective effects of ANP and cANP4-23 are mediated via sarcK<sub>ATP</sub> channel opening (<xref ref-type="bibr" rid="B52">Krylatov et al., 2021</xref>). ANP (atrial natriuretic peptide) positively regulates the function of the sarcK<sub>ATP</sub> channel in adult rabbit ventricular cardiomyocytes by activating NPR-A (natriuretic peptide receptor type A), an effect mediated by intracellular signaling mechanisms that cover PKG (cGMP-dependent protein kinase), ROS, ERK (extracellular signal-regulated protein kinase)1/2, CaMK II (calcium/calmodulin-dependent protein kinase II), and RyR (ryanodine receptor)-2; meanwhile, RyR2 (activation) is feasibly situated downstream of ROS/H<sub>2</sub>O<sub>2</sub>, which process enhances the opening frequency whereas it labilizes the long closures of the channel, thereby heightening channel activity (<xref ref-type="bibr" rid="B118">Zhang and Lin, 2020</xref>).</p>
</sec>
</sec>
<sec id="s3">
<title>Mutation of K<sub>ATP</sub> Channels</title>
<sec id="s3-1">
<title>Kir 6.1</title>
<p>Endothelium-expressed Kir6.1 is located on human chromosome 12p, and via elevated endothelin-1 release it controls vascular tone. Smooth muscle Kir6.1 gain-of-function mutation causes overt hypertension and hypotension; notably, autosomal dominant hypertension is related to chromosome 12p recombination, and postural hypotension is related to chromosome 12 (<xref ref-type="bibr" rid="B57">Li et al., 2013</xref>) (<xref ref-type="table" rid="T2">Table 2</xref>). In gain-of-function mutation Kir6.1 [GD-QR] (point mutations in two C-terminal residues of Kir6.1; Gly343Asp and Gln53Arg), lymphatic smooth muscle and vascular dysfunction are present, and lymphatic smooth muscle-specific expression subunit mutations result in profound lymphatic contractile dysfunction and lymphatic smooth muscle hyperpolarization rather than lymphatic endothelial cells (<xref ref-type="bibr" rid="B22">Davis et al., 2020</xref>). In a CS animal model, the Kir6.1<sup>wt/VM</sup> mutation directly and/or indirectly affects the skeletal muscle through vascular dysfunction, resulting in reduced limb strength, skeletal muscle atrophy, autophagy, and myofiber connective tissue replacement (<xref ref-type="bibr" rid="B90">Scala et al., 2020</xref>). The S422 L mutation, a missense mutation in the KCNJ8 gene, leads to a gain-of-function Kir6.1 channel, which leads to shortened repolarization in ventricular tissue; nevertheless, it could shorten repolarization in the atrium to increase atrial fibrillation susceptibility (<xref ref-type="bibr" rid="B23">Delaney et al., 2012</xref>).</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Monosubunit mutation and their locus and consequence.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Mutant Subunit</th>
<th align="center">Mutant Locus</th>
<th align="center">Consequence</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="5" align="left">Kir 6.1</td>
<td align="left">Smooth muscle</td>
<td align="left">Hypertension/hypotension</td>
</tr>
<tr>
<td align="left">Lymphatic smooth muscle</td>
<td align="left">Lymphatic contractile dysfunction lymphatic smooth muscle hyperpolarization</td>
</tr>
<tr>
<td align="left">Skeletal muscle</td>
<td align="left">Reduced limb strength, skeletal muscle atrophy, autophagy, and myofibers connective tissue replacement</td>
</tr>
<tr>
<td align="left">S422L</td>
<td align="left">Shortened repolarization in ventricular tissue</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Increase atrial fibrillation susceptibility</td>
</tr>
<tr>
<td rowspan="4" align="left">Kir 6.2</td>
<td align="left">Pancreatic islet cell</td>
<td align="left">Neonatal diabetes mellitus, maturity-onset diabetes of the young 13, type 2 diabetes mellitus, and even persistent hyperinsulinemic hypoglycemia of infancy</td>
</tr>
<tr>
<td align="left">rs5215&#xa0;G/G</td>
<td align="left">Vasodilation augment and shear stress reduction</td>
</tr>
<tr>
<td align="left">Hypertension mouse model</td>
<td align="left">Heart failure and death, myocardial incommensurate remodeling</td>
</tr>
<tr>
<td align="left">p.V59M</td>
<td align="left">Intellectual disability</td>
</tr>
<tr>
<td rowspan="4" align="left">SUR1</td>
<td align="left">Pancreas</td>
<td align="left">Neonatal diabetes</td>
</tr>
<tr>
<td align="left">V187D</td>
<td align="left">Higher insulin secretion in hypoglycemia and make K<sub>ATP</sub> channel acting pharmaceuticals out of action</td>
</tr>
<tr>
<td align="left">p.H1401Tfs</td>
<td align="left">Clinical heterogeneity congenital hyperinsulinemia</td>
</tr>
<tr>
<td align="left">Unstated</td>
<td align="left">Increased channel activity in MgATP/MgADP, reduced the K<sub>ATP</sub> channel surface expression</td>
</tr>
<tr>
<td align="left">SUR2A</td>
<td align="left">Fs1524 and A1513T</td>
<td align="left">Severely dilated hearts with impaired systolic function and arrhythmia</td>
</tr>
<tr>
<td rowspan="2" align="left">SUR2B</td>
<td align="left">R659C</td>
<td align="left">Heart disease and early repolarization syndrome</td>
</tr>
<tr>
<td align="left">C24S and C1455S</td>
<td align="left">Prevent the detrimental effects of sulfhydration and NaHS-induced tyrosine nitration</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3-2">
<title>Kir 6.2</title>
<p>Approximately 38.5% of mutations in the KCNJ11 gene, which encodes Kir 6.2 and consists of a single exon containing 390 amino acids, have been identified, which is associated with clinical diseases including but not limited to neonatal diabetes mellitus, maturity-onset diabetes of the young, type 2 diabetes mellitus, and even persistent hyperinsulinemic hypoglycemia of infancy (<xref ref-type="bibr" rid="B38">He et al., 2021</xref>). Patients with the E227K mutation in the KCNJ11 gene typically manifest with transient neonatal diabetes, which remits spontaneously, usually within 4&#x2013;60&#xa0;weeks of onset; however, more than half of these patients relapse into permanent diabetes in adolescence or early adulthood (<xref ref-type="bibr" rid="B25">Devaraja et al., 2020</xref>). rs5215 G/G (nucleotide change; G-A, amino acid change; Val337Ile) of the KCNJ11 gene, located at 11p15.1 and encoding the Kir6.2 subunit, causes valine-isoleucine substitution in exon 1,009 (ATC-GTC), and it is associated with a gain of function of the K<sub>ATP</sub> channel, leading to vasodilation augmentation and shear stress reduction, which protects humans from lower coronary microvascular dysfunction, reducing the risk of ischemic heart disease in women (<xref ref-type="bibr" rid="B91">Severino et al., 2020</xref>). In a hypertension mouse model, the Kir6.2 mutation led to heart failure and death, involving knockout mutation-induced myocardial incommensurate remodeling (<xref ref-type="bibr" rid="B63">Liu et al., 2021b</xref>). In neurons, Kir6.2 has critical roles in glucose sensing and neuronal excitability in response to metabolic demands, and the KCNJ11 p. V59 M mutation was strongly associated with intellectual disability (<xref ref-type="bibr" rid="B72">Moriguchi et al., 2018</xref>; <xref ref-type="bibr" rid="B102">Svalastoga et al., 2020</xref>).</p>
</sec>
<sec id="s3-3">
<title>SUR1</title>
<p>SUR1 is mainly expressed in the pancreas, and its mutations may lead to neonatal diabetes by disrupting inhibitory binding/gating or enhancing nucleotide stimulation. Some SUR1 mutant models in mice did not recapitulate the human phenotype (<xref ref-type="bibr" rid="B87">Sachse et al., 2020</xref>; <xref ref-type="bibr" rid="B106">Usher et al., 2020</xref>). SUR1-mutant (a homozygous c.560T &#x3e; A (V187D) mutation in exon four of the ABCC8 gene encoding the SUR1 protein) stem cell-derived islet-like clusters (SC islets) leads to increased beta-cell proliferation and mass, higher insulin secretion in hypoglycemia and makes K<sub>ATP</sub> channels-acting pharmaceuticals ineffective (<xref ref-type="bibr" rid="B62">Lithovius et al., 2021</xref>). The homozygous p. H1401Tfs ABCC8 mutation could cause significant clinical heterogeneity congenital hyperinsulinemia, ranging from a late-onset and diazoxide-responsive mild form to an extremely early-onset severe form requiring multimodality treatment with a full-course assessment of neurodevelopment and glycometabolism (<xref ref-type="bibr" rid="B103">Takasawa et al., 2021</xref>). Some SUR1 mutations resulted in increased channel activity in MgATP/MgADP and drastically reduced K<sub>ATP</sub> channel surface expression, which suggests that the overactive defects due to altered nucleotide sensitivities outweigh their biogenesis and surface expression defects and lead to an overall gain-of-channel-function effect and the neonatal diabetes mellitus disease phenotype (<xref ref-type="bibr" rid="B5">Balamurugan et al., 2019</xref>).</p>
</sec>
<sec id="s3-4">
<title>SUR2A</title>
<p>Due to the strong difficulties and inferior feasibility of single subunit mutation research, we mainly noted several common cases herein. In individuals with idiopathic dilated cardiomyopathy, two heterozygous mutations in exon 38 of ABCC9 encode at the C-terminal domain of SUR2A, Fs1524 (a frameshift at Leu1524, which introduces four anomalous terminal residues followed by a premature stop codon) and A1513T (a missense mutation (4537G&#x2192;A) causing the amino acid substitution), substantially diminishing the maximal rate of the NBD2 ATPase reaction without altering the Michaelis-Menten constant of catalysis, resulting in abnormal hydrolytic dynamics of the regulatory channel subunits, disrupting catalysis-dependent gating and impairing metabolic decoding, resulting in severely dilated hearts with impaired systolic function and arrhythmia (<xref ref-type="bibr" rid="B9">Bienengraeber et al., 2004</xref>).</p>
</sec>
<sec id="s3-5">
<title>SUR2B</title>
<p>The SUR2B mutation R659C located in the secondary structure region in the L1 linker (it has the greatest <italic>&#x3b1;</italic>-helical propensity) most stably interacts with NBD1, which could cause heart disease and even lead to early repolarization syndrome, a life-threatening condition (<xref ref-type="bibr" rid="B99">Sooklal et al., 2018</xref>). During colonic inflammation, two specific mutations within SUR2B (C24S and C1455S) prevent the detrimental effects of sulfhydration and NaHS-induced tyrosine nitration from reducing the pore-forming subunit (Kir6.1) (<xref ref-type="bibr" rid="B49">Kang et al., 2015</xref>).</p>
</sec>
<sec id="s3-6">
<title>Multiple Subunits Mutations of K<sub>ATP</sub> Channels</title>
<p>Cant&#xfa; syndrome (CS) is an ultrarare autosomal dominant inherited disorder caused by dominant gain-of-function mutations in both the SUR2A and Kir6.1 subunits of the K<sub>ATP</sub> channel, which is also characterized by multiple cardiovascular abnormalities, including edema, pericardial effusion, pulmonary hypertension, dilated and tortuous blood vessels with decreased systemic vascular resistance, cerebrovascular defects, patent ductus arteriosus, and marked cardiac hypertrophy (<xref ref-type="bibr" rid="B14">Chen et al., 2019</xref>; <xref ref-type="bibr" rid="B15">Chihara et al., 2020</xref>; <xref ref-type="bibr" rid="B71">McClenaghan et al., 2020</xref>; <xref ref-type="bibr" rid="B119">Zhang et al., 2021a</xref>) (<xref ref-type="table" rid="T3">Table 3</xref>). CHI is a rare genetically heterogeneous disorder caused by inactivating mutations in the SUR1 and Kir6.2 subunits of the K<sub>ATP</sub> channel and it is characterized by persistent hypoglycemia in infants and children, which may increase the risk of permanent brain damage (<xref ref-type="bibr" rid="B10">Boodhansingh et al., 2019</xref>; <xref ref-type="bibr" rid="B84">Rosenfeld et al., 2019</xref>; <xref ref-type="bibr" rid="B69">M&#xe4;nnist&#xf6; et al., 2020</xref>; <xref ref-type="bibr" rid="B85">Rosenfeld et al., 2021</xref>). NDM is characterized by the development of hyperglycemia within the first 6 months of life, beta-cell destruction, pancreatic hypoplasia or aplasia, impaired beta-cell function or severe insulin resistance resulting from impaired insulin secretion caused by gain-of-function mutations in KCNJ11 and/or ABCC8 subunits of the K<sub>ATP</sub> channel, which can be divided into two transient diabetes mellitus (TNDM) and perma-nent diabetes mellitus (PNDM) clinical subtypes, depending on the length of the disease course (<xref ref-type="bibr" rid="B13">Cao et al., 2020</xref>; <xref ref-type="bibr" rid="B21">Dahl and Kumar, 2020</xref>; <xref ref-type="bibr" rid="B79">Pipatpolkai et al., 2020</xref>; <xref ref-type="bibr" rid="B42">Horita et al., 2021</xref>). DEND syndrome is a severe pathological condition of neonatal diabetes with developmental delay, muscle weakness, and epilepsy caused by gain-of-function mutations in Kir 6.2 and SUR1 (<xref ref-type="bibr" rid="B21">Dahl and Kumar, 2020</xref>; <xref ref-type="bibr" rid="B79">Pipatpolkai et al., 2020</xref>; <xref ref-type="bibr" rid="B33">Gopi et al., 2021</xref>). AIMS is characterized by delayed psychomotor development with intellectual disability, anxiety, muscle weakness and fatigability and some shared dysmorphic features caused by loss-of-function mutations in ABCC9 (SUR2A and/or SUR2B) (<xref ref-type="bibr" rid="B96">Smeland et al., 2019</xref>).</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Multiple subunit mutation-related disease and clinical manifestations.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Mutant Subunit</th>
<th align="center">Diseases</th>
<th align="center">Clinical Features</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">SUR2A and Kir6.1</td>
<td align="left">Cant&#xfa; syndrome</td>
<td align="left">Edema, pericardial effusion, pulmonary hypertension, dilated and tortuous blood vessels with decreased systemic vascular resistance, and patent ductus arteriosus and cerebrovascular defects, patent ductus arteriosus, and marked cardiac hypertrophy</td>
</tr>
<tr>
<td align="left">SUR1 and Kir6.2</td>
<td align="left">Congenital hyperinsulinism</td>
<td align="left">Persistent hypoglycemia in infants and children</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left">High risk of permanent brain damage</td>
</tr>
<tr>
<td align="left">KCNJ11 and/or ABCC8 subunits</td>
<td align="left">Neonatal diabetes</td>
<td align="left">The first 6 months of life, beta-cell destruction, pancreatic hypoplasia or aplasia, impaired beta-cell function or severe insulin resistance</td>
</tr>
<tr>
<td align="left">Kir 6.2 and SUR1</td>
<td align="left">DEND syndrome</td>
<td align="left">Neonatal diabetes with developmental delay, muscle weakness, and epilepsy</td>
</tr>
<tr>
<td align="left">SUR2A and/or SUR2B</td>
<td align="left">ABCC9-related intellectual disability myopathy syndrome</td>
<td align="left">Intellectual disability, anxiety, muscle weakness and fatigability, and some shared dysmorphic features</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec id="s4">
<title>Regulation of K<sub>ATP</sub> Channels by Small Active Molecules</title>
<sec id="s4-1">
<title>Hydrogen Sulfide</title>
<p>Hydrogen sulfide (H<sub>2</sub>S), as a gaseous signaling molecule, has a wide range of biological functions, including vasodilatation, anti-endoplasmic reticulum stress, anti-apoptotic and anti-inflammatory functions, and it contributes to ameliorating ventricular structural remodeling and cardiac function (<xref ref-type="bibr" rid="B61">Li et al., 2021</xref>). In cardiac tissue, the most important enzyme for the synthesis of H<sub>2</sub>S is cystathionine &#x3b3;-lyase (CSE), which has reduced activity in atherosclerotic patients connected with angina and atrial fibrillation (<xref ref-type="bibr" rid="B8">Bibli et al., 2021</xref>) (<xref ref-type="fig" rid="F3">Figure 3</xref>). H<sub>2</sub>S has many significant bioactivities, including cytoprotective, antioxidant, anti-inflammatory, anti-apoptotic, and smooth muscle relaxing effects, in part because it acts as a K<sub>ATP</sub> channel opener (<xref ref-type="bibr" rid="B29">Fouad et al., 2020</xref>). H<sub>2</sub>S partially inhibits phosphodiesterase-5 through the activation of K<sub>ATP</sub> channels and increases intracellular cGMP to evoke direct vasorelaxing responses (<xref ref-type="bibr" rid="B16">Citi et al., 2020</xref>). H<sub>2</sub>S activates the K<sub>ATP</sub> channel and inhibits insulin secretion in INS-1E cells (a pancreatic <italic>&#xdf;</italic>-cell line), but the function of hyperpolarizing the plasma membrane and closing voltage-gated Ca<sup>2&#x2b;</sup> channels is not mediated by the K<sub>ATP</sub> channel (<xref ref-type="bibr" rid="B66">Lu et al., 2019</xref>; <xref ref-type="bibr" rid="B93">Shoji et al., 2019</xref>). H<sub>2</sub>S modulates K<sub>ATP</sub> channel activity, promotes protective effects against pulmonary hypertension and increases uterine blood flow by antagonizing vasoconstriction (<xref ref-type="bibr" rid="B36">Guerra and Hurt, 2019</xref>; <xref ref-type="bibr" rid="B86">Roubenne et al., 2021</xref>). H<sub>2</sub>S protects the embryonic heart from I/R injury by opening the K<sub>ATP</sub> channel rather than increasing coronary artery flow, demonstrating that H<sub>2</sub>S treatment of the embryonic heart is independent of the mother and the underdeveloped placenta (<xref ref-type="bibr" rid="B40">Hess et al., 2020</xref>). NaHS, a rapid-releasing H<sub>2</sub>S donor, stimulates ANP secretion via the K<sub>ATP</sub> channel under hypoxic conditions, resulting in decreased blood pressure, ECF volume and antiproliferation of vascular smooth muscle cells in the cardiovascular system (<xref ref-type="bibr" rid="B117">Yu et al., 2019</xref>). Briefly, the interaction between H<sub>2</sub>S and K<sub>ATP</sub> plays an irreplaceable role in cardiovascular disease.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>The functional regulation of active small molecules on K<sub>ATP</sub> channels. <bold>(A)</bold> H<sub>2</sub>S participates in K<sub>ATP</sub> channel regulation. H<sub>2</sub>S acts on the corresponding organ/tissues/cytochemical small molecules in the oval through K<sub>ATP</sub> channels to produce physiological effects in a rectangular box. The black up and down arrows inside the ellipse represent increasing and decreasing, respectively. <bold>(B)</bold>. NO participates in K<sub>ATP</sub> channel regulation. The relative drugs in the ellipses produce physiological effects in the rectangular boxes through the K<sub>ATP</sub> channels and NO/CGMP signaling pathways, which the reaction goes in the direction of the arrows in the same color. <bold>(C)</bold>. O<sub>2</sub> participates in K<sub>ATP</sub> channel regulation. Hypoxia results in a decrease in ATP/ADP acting on K<sub>ATP</sub> channels to prevent action potential generation and cell contraction; The K<sub>ATP</sub> channel acts on skeletal muscle and affects O<sub>2</sub> transport to sustain submaximal exercise tolerance; The K<sub>ATP</sub> channel affects anterior cerebral circulation and total cerebral perfusion through O<sub>2</sub> transport to prevent action potential generation and cell contraction. The black up and down arrows inside the ellipse represent increasing and decreasing, respectively. <bold>(D)</bold>. Other small active molecules. CORM-3 can mimic the HO-1/CO pathway, activate mitoK<sub>ATP</sub> channels and elicit cardioprotection against hypoxia-reoxygenation injury by inhibiting the Na<sup>&#x2b;</sup>/HCO<sub>3</sub>
<sup>&#x2212;</sup> transporter; CORM-2 alleviates gastric lesions at the systemic level <italic>via</italic> K<sub>ATP</sub> channels, reducing gastric DNA oxidation and inflammatory responses; SO<sub>2</sub> plays a vasodilatory role through K<sub>ATP</sub> channel activation in the peripheral cardiovascular system at high concentrations (&#x3e;500&#xa0;&#x3bc;mol/L).</p>
</caption>
<graphic xlink:href="fphar-13-868401-g003.tif"/>
</fig>
</sec>
<sec id="s4-2">
<title>Nitric Oxide (NO)</title>
<p>The NO-cyclic guanosine monophosphate (cGMP) signaling pathway is a potential therapeutic target for heart failure, and a reduction in NO bioavailability may result in the decreased production of cGMP, which could lead to decreased protection against myocardial injury, vascular and ventricular sclerosis, fibrosis, hypertrophy, and cardiorenal syndrome (<xref ref-type="bibr" rid="B105">Udelson et al., 2020</xref>). K<sub>ATP</sub> channels can activate the L-arginine/NO/cGMP cascade pathway to induce membrane hyperpolarization, which results in shortening the action potential and restricting Ca<sup>2&#x2b;</sup> entry through Ca<sup>2&#x2b;</sup> channels, thus contributing to cardioprotection and vasodilatation (<xref ref-type="bibr" rid="B107">Wang et al., 2019a</xref>; <xref ref-type="bibr" rid="B44">Iguchi et al., 2019</xref>). Reductions in the arterial blood pressure effect of white mulberry fruit polysaccharides, the vascular relaxation effect of tetrahydropalmatine on rat aortae, and the vasodilatory effect of formaldehyde, either partially or completely, are all mediated by the NO/cGMP/K<sub>ATP</sub> pathway (<xref ref-type="bibr" rid="B107">Wang et al., 2019a</xref>; <xref ref-type="bibr" rid="B126">Zhou et al., 2019a</xref>; <xref ref-type="bibr" rid="B124">Zhao et al., 2019</xref>). Lipofundin MCT/LCT is involved in attenuating K<sub>ATP</sub> channel-induced vasodilation by inhibiting basally released endothelial NO and/or cGMP (<xref ref-type="bibr" rid="B55">Lee et al., 2020</xref>). The antinociceptive effects of methanol extracts of B. spectabilis, cardamonin and Lonchocarpus araripensis lectin ether are partially or completely mediated by the NO/cGMP/K<sub>ATP</sub> pathways (<xref ref-type="bibr" rid="B2">Assreuy et al., 2020</xref>; <xref ref-type="bibr" rid="B28">Ferdous et al., 2020</xref>; <xref ref-type="bibr" rid="B81">Pui Ping et al., 2020</xref>). The K<sub>ATP</sub> channel, a gastroprotective factor, is involved in the gastroprotective effects of N-acylarylhydrazone derivatives on ethanol-induced gastric lesions in mice via the NO/cGMP pathway (<xref ref-type="bibr" rid="B20">da Silva Monteiro et al., 2019</xref>). Therefore, the NO/cGMP/K<sub>ATP</sub> pathway is involved in a variety of organoprotective and vasodilative pharmacological processes.</p>
</sec>
<sec id="s4-3">
<title>Oxygen(O<sub>2</sub>)</title>
<p>The heart operates exclusively under aerobic metabolism and three factors, heart rate, contractility, and ventricular wall tension, require myocardial mitochondria for maintaining sufficient O<sub>2</sub> to sustain oxidative phosphorylation. Hypoxia causes the opening of the K<sub>ATP</sub> channel due to a decline in the ATP:ADP ratio, which couples cellular metabolism to excitability to prevent action potential generation and cell contraction, ultimately leading to coronary artery smooth muscle cell hyperpolarization and the closure of voltage-dependent Ca<sup>2&#x2b;</sup> channels and relaxation (<xref ref-type="bibr" rid="B115">Yang et al., 2020a</xref>). Vascular K<sub>ATP</sub> channels supporting skeletal muscle convective and diffusive O<sub>2</sub> transport and oxidative phosphorylation sustain submaximal exercise tolerance; conversely, K<sub>ATP</sub> channel inhibitors may exacerbate exercise intolerance in healthy rats (<xref ref-type="bibr" rid="B18">Colburn et al., 2020</xref>). Additionally, K<sub>ATP</sub> channel activation modulates the anterior circulation and total cerebral perfusion, contributing to cerebral blood flow and oxygen delivery responses to hypoxia, maintaining a constant cerebral blood supply, avoiding disturbances in the precise regulation of cerebral perfusion and oxygen delivery, and preventing severe tissue damage and even death (<xref ref-type="bibr" rid="B97">Smith et al., 2020</xref>).</p>
</sec>
<sec id="s4-4">
<title>Regulated by Other Factors</title>
<p>CORM-3, a water-soluble CO-releasing molecule that can mimic the HO-1/CO (heme oxygenase-1/carbon monoxide) pathway by liberating CO under appropriate conditions in biological systems, activates mitoK<sub>ATP</sub> channels and elicits cardioprotection against hypoxia-reoxygenation injury by inhibiting a bicarbonate transporter (most likely Na<sup>&#x2b;</sup>/HCO3<sup>&#x2212;</sup>) during reoxygenation (<xref ref-type="bibr" rid="B80">Portal et al., 2019</xref>). CORM-2 increases the gastric mucosal CO content and blood carboxyhemoglobin concentration, resulting in gastroprotection, alleviation of gastric lesions, decreased gastric DNA oxidation and the inflammatory response at the systemic level, which is partly mediated by K<sub>ATP</sub> channels (<xref ref-type="bibr" rid="B58">Li et al., 2019</xref>). Sulfur dioxide (SO<sub>2</sub>), a major toxic gas and environmental pollutant, plays a vasodilatory role through K<sub>ATP</sub> channel activation in the peripheral cardiovascular system at high concentrations (&#x3e;500&#xa0;&#x3bc;mol/L) (<xref ref-type="bibr" rid="B68">Magierowska et al., 2019</xref>). The search for signaling molecular regulatory pathways related to K<sub>ATP</sub> channels is still in progress.</p>
<p>Highly specific HCN 2 (hyperpolarization-activated, cyclic-nucleotide gated channels 2) in ventricular myocytes, an integral part of ventricular electric remodeling, and the reduced expression of its mRNA, leads to the downregulation of the K<sub>ATP</sub> channel current, which is one of the partial causes of arrhythmia in diabetic rats (<xref ref-type="bibr" rid="B37">Hadova et al., 2021</xref>; <xref ref-type="bibr" rid="B111">White et al., 2021</xref>). Exogenous cholesterol eliminated the increase in SUR2, suggesting that cholesterol may regulate K<sub>ATP</sub> channel expression and explain why patients with hypercholesterolemia were also able to cope with ischemic events (<xref ref-type="bibr" rid="B32">Geiger et al., 2021</xref>). Low-density lipoprotein (LDL)5, the most negatively charged subfraction of circulating LDL, which has been considered a novel factor for predicting coronary vascular disease and stroke, prolongs the APD and increases the current density of K<sub>ATP</sub> channels, and may induce arrhythmias (<xref ref-type="bibr" rid="B67">Ma et al., 2020</xref>). Under 5-Hz pacing conditions, the ATP-sensitive potassium current of ZFHX3 knockdown (zinc finger homeobox three gene) cells was increased compared with that under other conditions, confirming that ZFHX3 knockdown and tachypacing are related to increased stress (<xref ref-type="bibr" rid="B65">Lkhagva et al., 2021</xref>). Statins increased the ADP/ATP ratio and activated K<sub>ATP</sub> channels to dedifferentiate myofibroblasts, while inhibition of K<sub>ATP</sub> channels weakened the role of statin-induced myofibroblast dedifferentiation (<xref ref-type="bibr" rid="B27">Emelyanova et al., 2019</xref>). K<sub>ATP</sub> channels participate in the cardiomyocyte-specific expression of photoinduced proton pump inhibitors, hyperpolarizing the intact heart to terminate ventricular arrhythmias (<xref ref-type="bibr" rid="B30">Funken et al., 2019</xref>). Resistin, secreted by PVAT (the fat reserve surrounding blood vessels consisting of fat cells, immune cells, fibroblasts, and endothelial cells), did not alter K<sub>ATP</sub> channel-mediated relaxation in males, while K<sub>ATP</sub> channel-mediated relaxation was significantly reduced in females (<xref ref-type="bibr" rid="B95">Small et al., 2019</xref>).</p>
</sec>
</sec>
<sec id="s5">
<title>Clinical Therapy of Targeted K<sub>ATP</sub> Channels</title>
<p>The functional regulation of small active molecules on K<sub>ATP</sub> channels and the potential mechanisms of mutant K<sub>ATP</sub> channels have been introduced in the previous content, and the relevant clinical effects and pharmacological mechanisms of some irre-placeable K<sub>ATP</sub> channel openers and inhibitors will be introduced.</p>
<p>Nicorandil is a renowned cardioprotective drug that is characterized by opening K<sub>ATP</sub> channels. It participates in the regulation of multiple signaling pathways and can be used to treat arrhythmias, chronic heart failure, stable angina, and acute coronary syndromes, including post-PCI (percutaneous coronary intervention). Nicorandil regulates coronary blood flow, protects cardiomyocytes from ischemia-reperfusion injury, alleviates endothelial dysfunction and reduces myocardial necrosis due to its K<sub>ATP</sub> channel-opening effects, thereby relieving angina symptoms and limiting infarct size and subsequent severe ischemic insult (<xref ref-type="bibr" rid="B45">Jiang et al., 2021</xref>). A systematic review and meta-analysis demonstrated that nicorandil could effectively improve microvascular perfusion, alleviate microvascular spasms, reduce platelet aggregation, open K<sub>ATP</sub> channels, reduce the excessive production of oxygen free radicals and myocardial ischemia, improve myocardial antioxidant capacity, and inhibit myocardial apoptosis and inflammatory reactions after ischemia to treat unstable angina pectoris and related microvascular complications (<xref ref-type="bibr" rid="B122">Zhang et al., 2021b</xref>).</p>
<p>Levosimendan is a calcium sensitization agent and K<sub>ATP</sub> channel opener that is clinically used for the treatment of decompensated heart failure, which is characterized by inducing vasodilation of the pulmonary, coronary, and peripheral arteries and venous circulation, anti-inflammatory and antioxidant effects, and then it exerts a cardioprotective effect in various settings (<xref ref-type="bibr" rid="B39">Herpain et al., 2019</xref>; <xref ref-type="bibr" rid="B26">Efentakis et al., 2020</xref>). Levosimendan may be considered for the prevention of overt acute heart failure and cardiogenic shock due to its hemodynamic and anti-ischemia effects and its pharmacodynamic properties (<xref ref-type="bibr" rid="B19">Cosentino et al., 2020</xref>).</p>
<p>Sulfonamides, as an antibacterial drug, Marcel Janbon discovered its hypoglycemic side effects, and A. Loubati&#xe8;res proved that its hypoglycemic mechanism is to promote insulin secretion, so they were widely used in clinic as hypoglycemic drugs (<xref ref-type="bibr" rid="B120">Zhang et al., 2013</xref>). In pancreatic <italic>&#xdf;</italic> cells, when blood glucose concentration increases, intracellular ATP concentration increases with active glucose uptake and metabolism and inhibits K<sub>ATP</sub> channels, leading to cell plasma membrane depolarization, activation of voltage-gated calcium channels, and calcium influx triggering insulin release (<xref ref-type="bibr" rid="B113">Yang et al., 2020b</xref>). Sulfonamides bind to K<sub>ATP</sub> channel sulfonylurea receptors, inhibit the opening of K<sub>ATP</sub> channel, promote the release of insulin, and reduce blood glucose and the risk of microvascular complications associated with diabetes (<xref ref-type="bibr" rid="B109">Wang et al., 2019b</xref>). Sulfonylureas might increase the risk of adverse cardiovascular events, due to K<sub>ATP</sub> channel closure in the heart, in Neil Dhopeshwarkar et al. cohort included 268,094 glipizide users and 124,354 glimepiride users in Medicaid, they found that glimepiride (as opposed to glipizide) was associated with an elevated risk of sudden cardiac death/fatal ventricular arrhythmia, in Abdelmoneim et al. cohort included 7,441 gliclazide and 13 884 glyburide users, and they observed that statistically significant 14% higher risk of acute coronary syndrome was observed in patients taking glyburide compared with those taking gliclazide (<xref ref-type="bibr" rid="B56">Leroy et al., 2006</xref>; <xref ref-type="bibr" rid="B83">Rieg et al., 2020</xref>). In conclusion, the exploration of pancreatic specific K<sub>ATP</sub> channel inhibitors can help control patients&#x2019; blood glucose, reduce microvascular complications.</p>
<p>At present, there is no specific pharmacotherapeutic treatment options are currently suitable for the diseases of K<sub>ATP</sub> channels mutation (<xref ref-type="bibr" rid="B84">Rosenfeld et al., 2019</xref>). Glibenclamide inhibited K<sub>ATP</sub> and slightly improved sensorimotor performance in DEND patients, but did not improve cognitive deficits caused by neuronal K<sub>ATP</sub> gain-of-function expression (<xref ref-type="bibr" rid="B46">Jin et al., 2020</xref>). Glibenclamide directly act on SUR1, leading to the closure of K<sub>ATP</sub> channel and the normal release of insulin, improving the growth imbalance, nervous system disorders and muscle strength of some PNDM children, but may cause hypoglycemia, temporary diarrhea, tooth staining, long Q-T syndrome and other adverse reactions (<xref ref-type="bibr" rid="B13">Cao et al., 2020</xref>). Chen et al. verified that Cant&#xfa; Mutations C166S (Kir6.2) and S1020P (SUR2A) are inhibited by travoprost, betaxolol, and ritodrine, meanwhile, these compounds are not known to cause cardiac side effects or hypoglycemia (<xref ref-type="bibr" rid="B14">Chen et al., 2019</xref>). Scala et al. &#x2018;s animal experiments demonstrated that glibenclamide treatment may help to reverse or avoid muscle weakness and atrophy in CS (<xref ref-type="bibr" rid="B60">Li et al., 2020b</xref>). In addition, in partially effective treatment regimens for patients with CHI, diazoxide opens the sarcK<sub>ATP</sub> channel and inhibits insulin secretion, octreopeptide and long-acting somatostatin analogues act downstream of the K<sub>ATP</sub> channel, inhibition of insulin secretion, subtotal pancreatectomy is used to reduce insulin production in focal and medically responsive non-focal cases (<xref ref-type="bibr" rid="B84">Rosenfeld et al., 2019</xref>). K<sub>ATP</sub> openers may indeed prove beneficial in some AIMS patients (<xref ref-type="bibr" rid="B8">Bibli et al., 2021</xref>). K<sub>ATP</sub> channel activator tifenazoxide, VU0071063 can be unlocked by opening the K<sub>ATP</sub> channel, providing CHI patients with a new pharmacological option for CHI therapy to maintain normal blood glucose and reduce drug side effects and postoperative complications (<xref ref-type="bibr" rid="B94">Sim et al., 2002</xref>). Interestingly, CRISPR-based genome editing techniques were found to detect changes in ABCC8 and SUR1 expression levels in type 2 diabetes, suggesting that gene editing could be useful in diagnosing and treating K<sub>ATP</sub> channel mutations in the future (<xref ref-type="bibr" rid="B125">Zhou et al., 2019b</xref>).</p>
</sec>
<sec sec-type="conclusion" id="s6">
<title>Conclusion</title>
<p>At present, no specific pharmacotherapeutic treatment options are currently suitable for CS, but glibenclamide can partially reverse the vascular symptoms of CS by inhibiting the overactivity of the K<sub>ATP</sub> channel (<xref ref-type="bibr" rid="B71">McClenaghan et al., 2020</xref>; <xref ref-type="bibr" rid="B54">Laimon et al., 2021</xref>). Sulfonylureas can inhibit the effect of ABCC8 and KCNJ11 activation mutations that prevent the closure of K<sub>ATP</sub> channels leading to insulin deficiency, reversing a condition that has historically been treated only with insulin (<xref ref-type="bibr" rid="B54">Laimon et al., 2021</xref>). The early ascertainment of a genetic diagnosis help us find the underlying cause which is the optimal treatment of the diseases of mutations in K<sub>ATP</sub> channels. These facts support the hypothesis that the study of K<sub>ATP</sub> channels may improve the prognosis, alleviate pain, and reduce the economic burden on patients. In the short run, Patients with cardiovascular disease and refractory K<sub>ATP</sub> channel subunit mutations will have more treatment options, more promising outcomes, and acceptable medical costs.</p>
</sec>
</body>
<back>
<sec id="s7">
<title>Author Contributions</title>
<p>ZW contributed to literature search, and drafted the manuscript; WB, YY contributed to literature search; D-MZ contributed to review design, wrote and revised the manuscript. All authors reviewed the manuscript.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>This work was supported by the National Natural Science Foundation of China (81370304, 81970342), Jiangsu Provincial Key Research and Development Program (BE2018611).</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>We thank all lab members for helpful discussion.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akhtar</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Lorenzini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pavlou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ochoa</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>O&#x27;Mahony</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Restrepo-Cordoba</surname>
<given-names>M. A.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Association of Left Ventricular Systolic Dysfunction Among Carriers of Truncating Variants in Filamin C with Frequent Ventricular Arrhythmia and End-Stage Heart Failure</article-title>. <source>JAMA Cardiol.</source> <volume>6</volume> (<issue>8</issue>), <fpage>891</fpage>&#x2013;<lpage>901</lpage>. <pub-id pub-id-type="doi">10.1001/jamacardio.2021.1106</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Assreuy</surname>
<given-names>A. M. S.</given-names>
</name>
<name>
<surname>Amorim</surname>
<given-names>R. M. F.</given-names>
</name>
<name>
<surname>Martins</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>de Queiroz Martins</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Cajazeiras</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>da Silva</surname>
<given-names>M. T. L.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Antinociceptive Effect of Lonchocarpus Araripensis Lectin: Activation of L-arginine/NO/cGMP/K&#x2b;ATP Signaling Pathway</article-title>. <source>Inflammopharmacology</source> <volume>28</volume> (<issue>6</issue>), <fpage>1623</fpage>&#x2013;<lpage>1631</lpage>. <pub-id pub-id-type="doi">10.1007/s10787-020-00729-z</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aziz</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Moyes</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Ang</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Vascular KATP Channels Protect from Cardiac Dysfunction and Preserve Cardiac Metabolism during Endotoxemia</article-title>. <source>J. Mol. Med. Berl.</source> <volume>98</volume> (<issue>8</issue>), <fpage>1149</fpage>&#x2013;<lpage>1160</lpage>. <pub-id pub-id-type="doi">10.1007/s00109-020-01946-3</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bai</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Cardioprotective Effect of Anisodamine against Ischemia/reperfusion Injury through the Mitochondrial ATP-Sensitive Potassium Channel</article-title>. <source>Eur. J. Pharmacol.</source> <volume>901</volume>, <fpage>174095</fpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2021.174095</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balamurugan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kavitha</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Mohan</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Radha</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Shyng</surname>
<given-names>S. L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Functional Characterization of Activating Mutations in the Sulfonylurea Receptor 1 (ABCC8) Causing Neonatal Diabetes Mellitus in Asian Indian Children</article-title>. <source>Pediatr. Diabetes</source> <volume>20</volume> (<issue>4</issue>), <fpage>397</fpage>&#x2013;<lpage>407</lpage>. <pub-id pub-id-type="doi">10.1111/pedi.12843</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basalay</surname>
<given-names>M. V.</given-names>
</name>
<name>
<surname>Yellon</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Davidson</surname>
<given-names>S. M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Targeting Myocardial Ischaemic Injury in the Absence of Reperfusion</article-title>. <source>Basic Res. Cardiol.</source> <volume>115</volume> (<issue>6</issue>), <fpage>63</fpage>. <pub-id pub-id-type="doi">10.1007/s00395-020-00825-9</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bezerra Pal&#xe1;cio</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Brito Lucas</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Varlla de Lacerda Alexandre</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Oliveira Cunha</surname>
<given-names>P. L.</given-names>
</name>
<name>
<surname>Ponte Viana</surname>
<given-names>Y. I.</given-names>
</name>
<name>
<surname>Albuquerque</surname>
<given-names>A. C.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Pharmacological and Molecular Docking Studies Reveal that Glibenclamide Competitively Inhibits Diazoxide-Induced Mitochondrial ATP-Sensitive Potassium Channel Activation and Pharmacological Preconditioning</article-title>. <source>Eur. J. Pharmacol.</source> <volume>908</volume>, <fpage>174379</fpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2021.174379</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bibli</surname>
<given-names>S. I.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Looso</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Weigert</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ratiu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wittig</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Mapping the Endothelial Cell S-Sulfhydrome Highlights the Crucial Role of Integrin Sulfhydration in Vascular Function</article-title>. <source>Circulation</source> <volume>143</volume> (<issue>9</issue>), <fpage>935</fpage>&#x2013;<lpage>948</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.120.051877</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bienengraeber</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Selivanov</surname>
<given-names>V. A.</given-names>
</name>
<name>
<surname>Kathmann</surname>
<given-names>E. C.</given-names>
</name>
<name>
<surname>O&#x27;Cochlain</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>ABCC9 Mutations Identified in Human Dilated Cardiomyopathy Disrupt Catalytic KATP Channel Gating</article-title>. <source>Nat. Genet.</source> <volume>36</volume> (<issue>4</issue>), <fpage>382</fpage>&#x2013;<lpage>387</lpage>. <pub-id pub-id-type="doi">10.1038/ng1329</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boodhansingh</surname>
<given-names>K. E.</given-names>
</name>
<name>
<surname>Kandasamy</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mitteer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Givler</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>De Leon</surname>
<given-names>D. D.</given-names>
</name>
<name>
<surname>Shyng</surname>
<given-names>S. L.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Novel Dominant KATP Channel Mutations in Infants with Congenital Hyperinsulinism: Validation by <italic>In Vitro</italic> Expression Studies and <italic>In Vivo</italic> Carrier Phenotyping</article-title>. <source>Am. J. Med. Genet. A</source> <volume>179</volume> (<issue>11</issue>), <fpage>2214</fpage>&#x2013;<lpage>2227</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.61335</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bou-Teen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kaludercic</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Weissman</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Turan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Maack</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Di Lisa</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Mitochondrial ROS and Mitochondria-Targeted Antioxidants in the Aged Heart</article-title>. <source>Free Radic. Biol. Med.</source> <volume>167</volume>, <fpage>109</fpage>&#x2013;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2021.02.043</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brennan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sims</surname>
<given-names>M. W.</given-names>
</name>
<name>
<surname>Hudman</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Norman</surname>
<given-names>R. I.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Early Opening of Sarcolemmal ATP-Sensitive Potassium Channels Is Not a Key Step in PKC-Mediated Cardioprotection</article-title>. <source>J. Mol. Cell Cardiol.</source> <volume>79</volume>, <fpage>42</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2014.10.016</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Clinical Features and Partial Proportional Molecular Genetics in Neonatal Diabetes Mellitus: a Retrospective Analysis in Southwestern China</article-title>. <source>Endocrine</source> <volume>69</volume> (<issue>1</issue>), <fpage>53</fpage>&#x2013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1007/s12020-020-02279-4</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Garon</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wieder</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Houtman</surname>
<given-names>M. J. C.</given-names>
</name>
<name>
<surname>Zangerl-Plessl</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Langer</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Computational Identification of Novel Kir6 Channel Inhibitors</article-title>. <source>Front. Pharmacol.</source> <volume>10</volume>, <fpage>549</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2019.00549</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chihara</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Asahina</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Itoh</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>A Novel Mutation in the KCNJ8 Gene Encoding the Kir6.1 Subunit of an ATP-Sensitive Potassium Channel in a Japanese Patient with Cant&#xfa; Syndrome</article-title>. <source>J. Eur. Acad. Dermatol Venereol.</source> <volume>34</volume> (<issue>9</issue>), <fpage>e476</fpage>&#x2013;<lpage>e478</lpage>. <pub-id pub-id-type="doi">10.1111/jdv.16384</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Citi</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Martelli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bucci</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Piragine</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Testai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Vellecco</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Searching for Novel Hydrogen Sulfide Donors: The Vascular Effects of Two Thiourea Derivatives</article-title>. <source>Pharmacol. Res.</source> <volume>159</volume>, <fpage>105039</fpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2020.105039</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colareda</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Ragone</surname>
<given-names>M. I.</given-names>
</name>
<name>
<surname>Bonazzola</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Consolini</surname>
<given-names>A. E.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The mKATP Channels and Protein-Kinase C Are Involved in the Cardioprotective Effects of Genistein on Estrogen-Deficient Rat Hearts Exposed to Ischemia/Reperfusion: Energetic Study</article-title>. <source>J. Cardiovasc Pharmacol.</source> <volume>75</volume> (<issue>5</issue>), <fpage>460</fpage>&#x2013;<lpage>474</lpage>. <pub-id pub-id-type="doi">10.1097/FJC.0000000000000816</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colburn</surname>
<given-names>T. D.</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Hageman</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Caldwell</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Schulze</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Ade</surname>
<given-names>C. J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Vascular ATP-Sensitive K&#x2b; Channels Support Maximal Aerobic Capacity and Critical Speed via Convective and Diffusive O2 Transport</article-title>. <source>J. Physiol.</source> <volume>598</volume> (<issue>21</issue>), <fpage>4843</fpage>&#x2013;<lpage>4858</lpage>. <pub-id pub-id-type="doi">10.1113/JP280232</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cosentino</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Niccoli</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Fracassi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rebuzzi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Agostoni</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Marenzi</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Rationale, Experimental Data, and Emerging Clinical Evidence on Early and Preventive Use of Levosimendan in Patients with Ventricular Dysfunction</article-title>. <source>Eur. Heart J. Cardiovasc Pharmacother.</source> <volume>6</volume> (<issue>5</issue>), <fpage>310</fpage>&#x2013;<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1093/ehjcvp/pvz065</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>da Silva Monteiro</surname>
<given-names>C. E.</given-names>
</name>
<name>
<surname>Franco</surname>
<given-names>&#xc1;. X.</given-names>
</name>
<name>
<surname>Sousa</surname>
<given-names>J. A. O.</given-names>
</name>
<name>
<surname>Matos</surname>
<given-names>V. E. A.</given-names>
</name>
<name>
<surname>de Souza</surname>
<given-names>E. P.</given-names>
</name>
<name>
<surname>Fraga</surname>
<given-names>C. A. M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Gastroprotective Effects of N-Acylarylhydrazone Derivatives on Ethanol-Induced Gastric Lesions in Mice Are Dependent on the NO/cGMP/KATP Pathway</article-title>. <source>Biochem. Pharmacol.</source> <volume>169</volume>, <fpage>113629</fpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2019.113629</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dahl</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Recent Advances in Neonatal Diabetes</article-title>. <source>Diabetes Metab. Syndr. Obes.</source> <volume>13</volume>, <fpage>355</fpage>&#x2013;<lpage>364</lpage>. <pub-id pub-id-type="doi">10.2147/DMSO.S198932</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davis</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Zawieja</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Castorena-Gonzalez</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Gui</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Kir6.1-dependent KATP Channels in Lymphatic Smooth Muscle and Vessel Dysfunction in Mice with Kir6.1 Gain-Of-Function</article-title>. <source>J. Physiol.</source> <volume>598</volume> (<issue>15</issue>), <fpage>3107</fpage>&#x2013;<lpage>3127</lpage>. <pub-id pub-id-type="doi">10.1113/JP279612</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delaney</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Muhammad</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Blair</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Kor</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fish</surname>
<given-names>F. A.</given-names>
</name>
<name>
<surname>Roden</surname>
<given-names>D. M.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>A KCNJ8 Mutation Associated with Early Repolarization and Atrial Fibrillation</article-title>. <source>Europace</source> <volume>14</volume> (<issue>10</issue>), <fpage>1428</fpage>&#x2013;<lpage>1432</lpage>. <pub-id pub-id-type="doi">10.1093/europace/eus150</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Demirbilek</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Galcheva</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vuralli</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Al-Khawaga</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Ion Transporters, Channelopathies, and Glucose Disorders</article-title>. <source>Int. J. Mol. Sci.</source> <volume>20</volume> (<issue>10</issue>), <fpage>2590</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20102590</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Devaraja</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Elder</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Non Classic Presentations of a Genetic Mutation Typically Associated with Transient Neonatal Diabetes</article-title>. <source>Endocrinol. Diabetes Metab. Case Rep.</source> <volume>2020</volume>, <fpage>2020</fpage>. <pub-id pub-id-type="doi">10.1530/EDM-19-0125</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Efentakis</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Varela</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chavdoula</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sigala</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Sanoudou</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tenta</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Levosimendan Prevents Doxorubicin-Induced Cardiotoxicity in Time- and Dose-dependent Manner: Implications for Inotropy</article-title>. <source>Cardiovasc Res.</source> <volume>116</volume> (<issue>3</issue>), <fpage>576</fpage>&#x2013;<lpage>591</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvz163</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Emelyanova</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sra</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schmuck</surname>
<given-names>E. G.</given-names>
</name>
<name>
<surname>Raval</surname>
<given-names>A. N.</given-names>
</name>
<name>
<surname>Downey</surname>
<given-names>F. X.</given-names>
</name>
<name>
<surname>Jahangir</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Impact of Statins on Cellular Respiration and De-differentiation of Myofibroblasts in Human Failing Hearts</article-title>. <source>Esc. Heart Fail</source> <volume>6</volume> (<issue>5</issue>), <fpage>1027</fpage>&#x2013;<lpage>1040</lpage>. <pub-id pub-id-type="doi">10.1002/ehf2.12509</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferdous</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Janta</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Arpa</surname>
<given-names>R. N.</given-names>
</name>
<name>
<surname>Afroze</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Moniruzzaman</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The Leaves of Bougainvillea Spectabilis Suppressed Inflammation and Nociception <italic>In Vivo</italic> through the Modulation of Glutamatergic, cGMP, and ATP-Sensitive K&#x2b; Channel Pathways</article-title>. <source>J. Ethnopharmacol.</source> <volume>261</volume>, <fpage>113148</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2020.113148</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fouad</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Hafez</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Hamouda</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Hydrogen Sulfide Modulates IL-6/STAT3 Pathway and Inhibits Oxidative Stress, Inflammation, and Apoptosis in Rat Model of Methotrexate Hepatotoxicity</article-title>. <source>Hum. Exp. Toxicol.</source> <volume>39</volume> (<issue>1</issue>), <fpage>77</fpage>&#x2013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1177/0960327119877437</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Funken</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Malan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Sasse</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bruegmann</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Optogenetic Hyperpolarization of Cardiomyocytes Terminates Ventricular Arrhythmia</article-title>. <source>Front. Physiol.</source> <volume>10</volume>, <fpage>498</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2019.00498</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garrott</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kuzmiak-Glancy</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wengrowski</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kay</surname>
<given-names>M. W.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>KATP Channel Inhibition Blunts Electromechanical Decline during Hypoxia in Left Ventricular Working Rabbit Hearts</article-title>. <source>J. Physiol.</source> <volume>595</volume> (<issue>12</issue>), <fpage>3799</fpage>&#x2013;<lpage>3813</lpage>. <pub-id pub-id-type="doi">10.1113/JP273873</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geiger</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fatima</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Schooley</surname>
<given-names>J. F.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Smyth</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Haigney</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Flagg</surname>
<given-names>T. P.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Novel Cholesterol-dependent Regulation of Cardiac KATP Subunit Expression Revealed Using Histone Deacetylase Inhibitors</article-title>. <source>Physiol. Rep.</source> <volume>8</volume> (<issue>24</issue>), <fpage>e14675</fpage>. <pub-id pub-id-type="doi">10.14814/phy2.14675</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gopi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kavitha</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kanthimathi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kannan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Joshi</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Genotype-phenotype Correlation of KATP Channel Gene Defects Causing Permanent Neonatal Diabetes in Indian Patients</article-title>. <source>Pediatr. Diabetes</source> <volume>22</volume> (<issue>1</issue>), <fpage>82</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1111/pedi.13109</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Griffiths</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Frenneaux</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Feelisch</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Madhani</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Nitrite and Myocardial Ischaemia Reperfusion Injury. Where Are We Now?</article-title> <source>Pharmacol. Ther.</source> <volume>223</volume>, <fpage>107819</fpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2021.107819</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grune</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yamazoe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nahrendorf</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Electroimmunology and Cardiac Arrhythmia</article-title>. <source>Nat. Rev. Cardiol.</source> <volume>18</volume> (<issue>8</issue>), <fpage>547</fpage>&#x2013;<lpage>564</lpage>. <pub-id pub-id-type="doi">10.1038/s41569-021-00520-9</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guerra</surname>
<given-names>D. D.</given-names>
</name>
<name>
<surname>Hurt</surname>
<given-names>K. J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Gasotransmitters in Pregnancy: from Conception to Uterine Involution</article-title>. <source>Biol. Reprod.</source> <volume>101</volume> (<issue>1</issue>), <fpage>4</fpage>&#x2013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1093/biolre/ioz038</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hadova</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kralova</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Doka</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bies Pivackova</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kmecova</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Krenek</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Isolated Downregulation of HCN2 in Ventricles of Rats with Streptozotocin-Induced Diabetic Cardiomyopathy</article-title>. <source>BMC Cardiovasc Disord.</source> <volume>21</volume> (<issue>1</issue>), <fpage>118</fpage>. <pub-id pub-id-type="doi">10.1186/s12872-021-01929-3</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Continuous Spectrum of Glucose Dysmetabolism Due to the KCNJ11 Gene Mutation-Case Reports and Review of the Literature</article-title>. <source>J. Diabetes</source> <volume>13</volume> (<issue>1</issue>), <fpage>19</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1111/1753-0407.13114</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herpain</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bouchez</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Girardis</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Guarracino</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Knotzer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper</article-title>. <source>J. Cardiovasc Pharmacol.</source> <volume>73</volume> (<issue>1</issue>), <fpage>3</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1097/FJC.0000000000000636</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hess</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Garrud</surname>
<given-names>T. A. C.</given-names>
</name>
<name>
<surname>Botting</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Ford</surname>
<given-names>S. G.</given-names>
</name>
<name>
<surname>Giussani</surname>
<given-names>D. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Embryonic Cardioprotection by Hydrogen Sulphide: Studies of Isolated Cardiac Function and Ischaemia-Reperfusion Injury in the Chicken Embryo</article-title>. <source>J. Physiol.</source> <volume>598</volume> (<issue>19</issue>), <fpage>4197</fpage>&#x2013;<lpage>4208</lpage>. <pub-id pub-id-type="doi">10.1113/JP279978</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heusch</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Myocardial Ischaemia-Reperfusion Injury and Cardioprotection in Perspective</article-title>. <source>Nat. Rev. Cardiol.</source> <volume>17</volume> (<issue>12</issue>), <fpage>773</fpage>&#x2013;<lpage>789</lpage>. <pub-id pub-id-type="doi">10.1038/s41569-020-0403-y</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horita</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ono</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gonzalez-Resines</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ono</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yamachi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Structure Based Analysis of KATP Channel with a DEND Syndrome Mutation in Murine Skeletal Muscle</article-title>. <source>Sci. Rep.</source> <volume>11</volume> (<issue>1</issue>), <fpage>6668</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-021-86121-5</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Nichols</surname>
<given-names>C. G.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Genetic Discovery of ATP-Sensitive K&#x2b; Channels in Cardiovascular Diseases</article-title>. <source>Circ. Arrhythm. Electrophysiol.</source> <volume>12</volume> (<issue>5</issue>), <fpage>e007322</fpage>. <pub-id pub-id-type="doi">10.1161/CIRCEP.119.007322</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iguchi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Saotome</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yamashita</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hasan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Maekawa</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Pinacidil, a KATP Channel Opener, Stimulates Cardiac Na&#x2b;/Ca2&#x2b; Exchanger Function through the NO/cGMP/PKG Signaling Pathway in guinea Pig Cardiac Ventricular Myocytes</article-title>. <source>Schmiedeb. Arch. Pharmacol.</source> <volume>392</volume> (<issue>8</issue>), <fpage>949</fpage>&#x2013;<lpage>959</lpage>. <pub-id pub-id-type="doi">10.1007/s00210-019-01642-1</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Protective Effect of Nicorandil on Cardiac Microvascular Injury: Role of Mitochondrial Integrity</article-title>. <source>Oxid. Med. Cell Longev.</source> <volume>2021</volume>, <fpage>4665632</fpage>. <pub-id pub-id-type="doi">10.1155/2021/4665632</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S. S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Methylglyoxal-induced miR-223 Suppresses Rat Vascular KATP Channel Activity by Downregulating Kir6.1 mRNA in Carbonyl Stress</article-title>. <source>Vasc. Pharmacol.</source> <volume>128-129</volume>, <fpage>106666</fpage>. <pub-id pub-id-type="doi">10.1016/j.vph.2020.106666</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jovanovic</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ballantyne</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Blagojevi&#x107;</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jovanovi&#x107;</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Phenylephrine Preconditioning in Embryonic Heart H9c2 Cells Is Mediated by Up-Regulation of SUR2B/Kir6.2: A First Evidence for Functional Role of SUR2B in Sarcolemmal K<sub>ATP</sub> Channels and Cardioprotection</article-title>. <source>Int. J. Biochem. Cell Biol.</source> <volume>70</volume>, <fpage>23</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2015.10.029</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaneko</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yano</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Itoh</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Morita</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kiriyama</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kamon</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline with Risk of Heart Failure and Atrial Fibrillation</article-title>. <source>Circulation</source> <volume>143</volume> (<issue>23</issue>), <fpage>2244</fpage>&#x2013;<lpage>2253</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.120.052624</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gade</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Akbarali</surname>
<given-names>H. I.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Interaction between Hydrogen Sulfide-Induced Sulfhydration and Tyrosine Nitration in the KATP Channel Complex</article-title>. <source>Am. J. Physiol. Gastrointest. Liver Physiol.</source> <volume>308</volume> (<issue>6</issue>), <fpage>G532</fpage>&#x2013;<lpage>G539</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.00281.2014</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kent</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>El Baradie</surname>
<given-names>K. B. Y.</given-names>
</name>
<name>
<surname>Hamrick</surname>
<given-names>M. W.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Targeting the Mitochondrial Permeability Transition Pore to Prevent Age-Associated Cell Damage and Neurodegeneration</article-title>. <source>Oxid. Med. Cell Longev.</source> <volume>2021</volume>, <fpage>6626484</fpage>. <pub-id pub-id-type="doi">10.1155/2021/6626484</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keung</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sen Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>A. O.</given-names>
</name>
<name>
<surname>Chopra</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>C. W.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Non-cell Autonomous Cues for Enhanced Functionality of Human Embryonic Stem Cell-Derived Cardiomyocytes via Maturation of Sarcolemmal and Mitochondrial KATP Channels</article-title>. <source>Sci. Rep.</source> <volume>6</volume>, <fpage>34154</fpage>. <pub-id pub-id-type="doi">10.1038/srep34154</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krylatov</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Tsibulnikov</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Mukhomedzyanov</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Boshchenko</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>V. E.</given-names>
</name>
<name>
<surname>Jaggi</surname>
<given-names>A. S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>The Role of Natriuretic Peptides in the Regulation of Cardiac Tolerance to Ischemia/Reperfusion and Postinfarction Heart Remodeling</article-title>. <source>J. Cardiovasc Pharmacol. Ther.</source> <volume>26</volume> (<issue>2</issue>), <fpage>131</fpage>&#x2013;<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1177/1074248420952243</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krylova</surname>
<given-names>I. B.</given-names>
</name>
<name>
<surname>Selina</surname>
<given-names>E. N.</given-names>
</name>
<name>
<surname>Bulion</surname>
<given-names>V. V.</given-names>
</name>
<name>
<surname>Rodionova</surname>
<given-names>O. M.</given-names>
</name>
<name>
<surname>Evdokimova</surname>
<given-names>N. R.</given-names>
</name>
<name>
<surname>Belosludtseva</surname>
<given-names>N. V.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Uridine Treatment Prevents Myocardial Injury in Rat Models of Acute Ischemia and Ischemia/reperfusion by Activating the Mitochondrial ATP-dependent Potassium Channel</article-title>. <source>Sci. Rep.</source> <volume>11</volume> (<issue>1</issue>), <fpage>16999</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-021-96562-7</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laimon</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>El-Ziny</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>El-Hawary</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Elsharkawy</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Salem</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Aboelenin</surname>
<given-names>H. M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Genetic and Clinical Heterogeneity of Permanent Neonatal Diabetes Mellitus: a Single Tertiary Centre Experience</article-title>. <source>Acta Diabetol.</source> <volume>58</volume> (<issue>12</issue>), <fpage>1689</fpage>&#x2013;<lpage>1700</lpage>. <pub-id pub-id-type="doi">10.1007/s00592-021-01788-6</pub-id> </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ok</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>S. I.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Lipofundin MCT/LCT Inhibits Levcromakalim-Induced Vasodilation by Inhibiting Endothelial Nitric Oxide Release</article-title>. <source>Int. J. Mol. Sci.</source> <volume>21</volume> (<issue>5</issue>), <fpage>1763</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21051763</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leroy</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Priv&#xe9;</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bourret</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Berthiaume</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ferraro</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Brochiero</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Regulation of ENaC and CFTR Expression with K&#x2b; Channel Modulators and Effect on Fluid Absorption across Alveolar Epithelial Cells</article-title>. <source>Am. J. Physiol. Lung Cell Mol. Physiol.</source> <volume>291</volume> (<issue>6</issue>), <fpage>L1207</fpage>&#x2013;<lpage>L1219</lpage>. <pub-id pub-id-type="doi">10.1152/ajplung.00376.2005</pub-id> </citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Knutsen</surname>
<given-names>R. H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Osei-Owusu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Moreno-Dominguez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Harter</surname>
<given-names>T. M.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Hypotension Due to Kir6.1 Gain-Of-Function in Vascular Smooth Muscle</article-title>. <source>J. Am. Heart Assoc.</source> <volume>2</volume> (<issue>4</issue>), <fpage>e000365</fpage>. <pub-id pub-id-type="doi">10.1161/JAHA.113.000365</pub-id> </citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>M. X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>W. L.</given-names>
</name>
<name>
<surname>Chai</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D. X.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>H. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Inhibitory Effects of Sulfur Dioxide within the Nucleus Tractus Solitarii of Rats: Involvement of Calcium Ion Channels, Adenine Nucleoside Triphosphate-Sensitive Potassium Channels, and the Nitric Oxide/cyclic Guanine Trinucleotide Phosphate Pathway</article-title>. <source>Neuroreport</source> <volume>30</volume> (<issue>13</issue>), <fpage>914</fpage>&#x2013;<lpage>920</lpage>. <pub-id pub-id-type="doi">10.1097/WNR.0000000000001304</pub-id> </citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Mechanism of the Hypoxia Inducible Factor 1/hypoxic Response Element Pathway in Rat Myocardial Ischemia/diazoxide Post-conditioning</article-title>. <source>Mol. Med. Rep.</source> <volume>21</volume> (<issue>3</issue>), <fpage>1527</fpage>&#x2013;<lpage>1536</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2020.10966</pub-id> </citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Aziz</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ojake</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tinker</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Endothelial ATP-Sensitive Potassium Channel Protects against the Development of Hypertension and Atherosclerosis</article-title>. <source>Hypertension</source> <volume>76</volume> (<issue>3</issue>), <fpage>776</fpage>&#x2013;<lpage>784</lpage>. <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.120.15355</pub-id> </citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X. Y.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>The Baroreflex Afferent Pathway Plays a Critical Role in H2S-Mediated Autonomic Control of Blood Pressure Regulation under Physiological and Hypertensive Conditions</article-title>. <source>Acta Pharmacol. Sin.</source> <volume>42</volume> (<issue>6</issue>), <fpage>898</fpage>&#x2013;<lpage>908</lpage>. <pub-id pub-id-type="doi">10.1038/s41401-020-00549-5</pub-id> </citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lithovius</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Saarim&#xe4;ki-Vire</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Balboa</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ibrahim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Montaser</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Barsby</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>SUR1-mutant iPS Cell-Derived Islets Recapitulate the Pathophysiology of Congenital Hyperinsulinism</article-title>. <source>Diabetologia</source> <volume>64</volume> (<issue>3</issue>), <fpage>630</fpage>&#x2013;<lpage>640</lpage>. <pub-id pub-id-type="doi">10.1007/s00125-020-05346-7</pub-id> </citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ying</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Clinical and Genetic Analysis of KATP Variants with Heart Failure Risk in Patients with Decreased Serum ApoA-I Levels</article-title>. <source>J. Clin. Endocrinol. Metab.</source> <volume>106</volume> (<issue>8</issue>), <fpage>2264</fpage>&#x2013;<lpage>2278</lpage>. <pub-id pub-id-type="doi">10.1210/clinem/dgab336</pub-id> </citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mo</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Cardioprotective Effect of Quercetin against Ischemia/Reperfusion Injury Is Mediated through NO System and Mitochondrial K-ATP Channels</article-title>. <source>Cell J.</source> <volume>23</volume> (<issue>2</issue>), <fpage>184</fpage>&#x2013;<lpage>190</lpage>. <pub-id pub-id-type="doi">10.22074/cellj.2021.7183</pub-id> </citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lkhagva</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y. K.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y. C.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>W. L.</given-names>
</name>
<name>
<surname>Higa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>Y. H.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>ZFHX3 Knockdown Dysregulates Mitochondrial Adaptations to Tachypacing in Atrial Myocytes through Enhanced Oxidative Stress and Calcium Overload</article-title>. <source>Acta Physiol. (Oxf)</source> <volume>231</volume> (<issue>4</issue>), <fpage>e13604</fpage>. <pub-id pub-id-type="doi">10.1111/apha.13604</pub-id> </citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mulvihill</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>ATP-sensitive K&#x2b; Channels and Mitochondrial Permeability Transition Pore Mediate Effects of Hydrogen Sulfide on Cytosolic Ca2&#x2b; Homeostasis and Insulin Secretion in &#x3b2;-cells</article-title>. <source>Pflugers Arch.</source> <volume>471</volume> (<issue>11-12</issue>), <fpage>1551</fpage>&#x2013;<lpage>1564</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-019-02325-9</pub-id> </citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J. X.</given-names>
</name>
<name>
<surname>Abbasi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Atherogenic L5 LDL Induces Cardiomyocyte Apoptosis and Inhibits KATP Channels through CaMKII Activation</article-title>. <source>Lipids Health Dis.</source> <volume>19</volume> (<issue>1</issue>), <fpage>189</fpage>. <pub-id pub-id-type="doi">10.1186/s12944-020-01368-7</pub-id> </citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Magierowska</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Korbut</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hubalewska-Mazgaj</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Surmiak</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chmura</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bakalarz</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Oxidative Gastric Mucosal Damage Induced by Ischemia/reperfusion and the Mechanisms of its Prevention by Carbon Monoxide-Releasing Tricarbonyldichlororuthenium (II) Dimer</article-title>. <source>Free Radic. Biol. Med.</source> <volume>145</volume>, <fpage>198</fpage>&#x2013;<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2019.09.032</pub-id> </citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>M&#xe4;nnist&#xf6;</surname>
<given-names>J. M. E.</given-names>
</name>
<name>
<surname>Maria</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Raivo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kuulasmaa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Otonkoski</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Huopio</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Clinical and Genetic Characterization of 153 Patients with Persistent or Transient Congenital Hyperinsulinism</article-title>. <source>J. Clin. Endocrinol. Metab.</source> <volume>105</volume> (<issue>4</issue>), <fpage>dgz271</fpage>. <pub-id pub-id-type="doi">10.1210/clinem/dgz271</pub-id> </citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>M. W.</given-names>
</name>
<name>
<surname>Shyng</surname>
<given-names>S. L.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Pharmacological Chaperones of ATP-Sensitive Potassium Channels: Mechanistic Insight from cryoEM Structures</article-title>. <source>Mol. Cell Endocrinol.</source> <volume>502</volume>, <fpage>110667</fpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2019.110667</pub-id> </citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McClenaghan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Harter</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Halabi</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Chalk</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Glibenclamide Reverses Cardiovascular Abnormalities of Cantu Syndrome Driven by KATP Channel Overactivity</article-title>. <source>J. Clin. Invest</source> <volume>130</volume> (<issue>3</issue>), <fpage>1116</fpage>&#x2013;<lpage>1121</lpage>. <pub-id pub-id-type="doi">10.1172/JCI130571</pub-id> </citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moriguchi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ishizuka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yabuki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shioda</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tagashira</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Blockade of the KATP Channel Kir6.2 by Memantine Represents a Novel Mechanism Relevant to Alzheimer&#x27;s Disease Therapy</article-title>. <source>Mol. Psychiatry</source> <volume>23</volume> (<issue>2</issue>), <fpage>211</fpage>&#x2013;<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2016.187</pub-id> </citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mulder</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>van Veldhuisen</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Rienstra</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Sudden Cardiac Death in Heart Failure: More Than Meets the Eye</article-title>. <source>Eur. J. Heart Fail</source> <volume>23</volume> (<issue>8</issue>), <fpage>1361</fpage>&#x2013;<lpage>1363</lpage>. <pub-id pub-id-type="doi">10.1002/ejhf.2212</pub-id> </citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noma</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>1983</year>). <article-title>ATP-regulated K&#x2b; Channels in Cardiac Muscle</article-title>. <source>Nature</source> <volume>305</volume> (<issue>5930</issue>), <fpage>147</fpage>&#x2013;<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1038/305147a0</pub-id> </citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paggio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Checchetto</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Campo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Menab&#xf2;</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Di Marco</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Di Lisa</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Identification of an ATP-Sensitive Potassium Channel in Mitochondria</article-title>. <source>Nature</source> <volume>572</volume> (<issue>7771</issue>), <fpage>609</fpage>&#x2013;<lpage>613</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-019-1498-3</pub-id> </citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papanicolaou</surname>
<given-names>K. N.</given-names>
</name>
<name>
<surname>Ashok</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Global Knockout of ROMK Potassium Channel Worsens Cardiac Ischemia-Reperfusion Injury but Cardiomyocyte-specific Knockout Does Not: Implications for the Identity of mitoKATP</article-title>. <source>J. Mol. Cell Cardiol.</source> <volume>139</volume>, <fpage>176</fpage>&#x2013;<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2020.01.010</pub-id> </citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pereira</surname>
<given-names>O.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Kowaltowski</surname>
<given-names>A. J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Mitochondrial K&#x2b; Transport: Modulation and Functional Consequences</article-title>. <source>Molecules</source> <volume>26</volume> (<issue>10</issue>), <fpage>2935</fpage>. <pub-id pub-id-type="doi">10.3390/molecules26102935</pub-id> </citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pertiwi</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>Hillman</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Chilton</surname>
<given-names>E. L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Ischemia Reperfusion Injury Produces, and Ischemic Preconditioning Prevents, Rat Cardiac Fibroblast Differentiation: Role of KATP Channels</article-title>. <source>J. Cardiovasc Dev. Dis.</source> <volume>6</volume> (<issue>2</issue>), <fpage>22</fpage>. <pub-id pub-id-type="doi">10.3390/jcdd6020022</pub-id> </citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pipatpolkai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Usher</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Stansfeld</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Ashcroft</surname>
<given-names>F. M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>New Insights into KATP Channel Gene Mutations and Neonatal Diabetes Mellitus</article-title>. <source>Nat. Rev. Endocrinol.</source> <volume>16</volume> (<issue>7</issue>), <fpage>378</fpage>&#x2013;<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1038/s41574-020-0351-y</pub-id> </citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Portal</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Morin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Motterlini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ghaleh</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Pons</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The CO-releasing Molecule CORM-3 Protects Adult Cardiomyocytes against Hypoxia-Reoxygenation by Modulating pH Restoration</article-title>. <source>Eur. J. Pharmacol.</source> <volume>862</volume>, <fpage>172636</fpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2019.172636</pub-id> </citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pui Ping</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Akhtar</surname>
<given-names>M. N.</given-names>
</name>
<name>
<surname>Israf</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Perimal</surname>
<given-names>E. K.</given-names>
</name>
<name>
<surname>Sulaiman</surname>
<given-names>M. R.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Possible Participation of Ionotropic Glutamate Receptors and L-Arginine-Nitric Oxide-Cyclic Guanosine Monophosphate-ATP-Sensitive K&#x2b; Channel Pathway in the Antinociceptive Activity of Cardamonin in Acute Pain Animal Models</article-title>. <source>Molecules</source> <volume>25</volume> (<issue>22</issue>), <fpage>5385</fpage>. <pub-id pub-id-type="doi">10.3390/molecules25225385</pub-id> </citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rameshrad</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Omidkhoda</surname>
<given-names>S. F.</given-names>
</name>
<name>
<surname>Razavi</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>Hosseinzadeh</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Evaluating the Possible Role of Mitochondrial ATP-Sensitive Potassium Channels in the Cardioprotective Effects of Morin in the Isolated Rat Heart</article-title>. <source>Life Sci.</source> <volume>264</volume>, <fpage>118659</fpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2020.118659</pub-id> </citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rieg</surname>
<given-names>A. D.</given-names>
</name>
<name>
<surname>Suleiman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>B&#xfc;nting</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Verjans</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Spillner</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schn&#xf6;ring</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Levosimendan Reduces Segmental Pulmonary Vascular Resistance in Isolated Perfused Rat Lungs and Relaxes Human Pulmonary Vessels</article-title>. <source>PLoS One</source> <volume>15</volume> (<issue>5</issue>), <fpage>e0233176</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0233176</pub-id> </citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosenfeld</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ganguly</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>De Leon</surname>
<given-names>D. D.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Congenital Hyperinsulinism Disorders: Genetic and Clinical Characteristics</article-title>. <source>Am. J. Med. Genet. C Semin. Med. Genet.</source> <volume>181</volume> (<issue>4</issue>), <fpage>682</fpage>&#x2013;<lpage>692</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.c.31737</pub-id> </citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosenfeld</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mitteer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Boodhansingh</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>McKnight</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Boyajian</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Case Report: Two Distinct Focal Congenital Hyperinsulinism Lesions Resulting from Separate Genetic Events</article-title>. <source>Front. Pediatr.</source> <volume>9</volume>, <fpage>699129</fpage>. <pub-id pub-id-type="doi">10.3389/fped.2021.699129</pub-id> </citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roubenne</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Marthan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Le Grand</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Guibert</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Hydrogen Sulfide Metabolism and Pulmonary Hypertension</article-title>. <source>Cells</source> <volume>10</volume> (<issue>6</issue>), <fpage>1477</fpage>. <pub-id pub-id-type="doi">10.3390/cells10061477</pub-id> </citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sachse</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Haythorne</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Proks</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cater</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ellard</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Phenotype of a Transient Neonatal Diabetes Point Mutation (SUR1-R1183w) in Mice</article-title>. <source>Wellcome Open Res.</source> <volume>5</volume>, <fpage>15</fpage>. <pub-id pub-id-type="doi">10.12688/wellcomeopenres.15529.2</pub-id> </citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakamoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kurokawa</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Involvement of Sex Hormonal Regulation of K&#x2b; Channels in Electrophysiological and Contractile Functions of Muscle Tissues</article-title>. <source>J. Pharmacol. Sci.</source> <volume>139</volume> (<issue>4</issue>), <fpage>259</fpage>&#x2013;<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1016/j.jphs.2019.02.009</pub-id> </citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Savarese</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Stolfo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Sinagra</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lund</surname>
<given-names>L. H.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Heart Failure with Mid-range or Mildly Reduced Ejection Fraction</article-title>. <source>Nat. Rev. Cardiol.</source> <volume>19</volume> (<issue>2</issue>), <fpage>100</fpage>&#x2013;<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1038/s41569-021-00605-5</pub-id> </citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scala</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Maqoud</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zizzo</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mele</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Camerino</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Zito</surname>
<given-names>F. A.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Pathophysiological Consequences of KATP Channel Overactivity and Pharmacological Response to Glibenclamide in Skeletal Muscle of a Murine Model of Cant&#xf9; Syndrome</article-title>. <source>Front. Pharmacol.</source> <volume>11</volume>, <fpage>604885</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2020.604885</pub-id> </citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Severino</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>D&#x27;Amato</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Netti</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pucci</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mariani</surname>
<given-names>M. V.</given-names>
</name>
<name>
<surname>Cimino</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Susceptibility to Ischaemic Heart Disease: Focusing on Genetic Variants for ATP-Sensitive Potassium Channel beyond Traditional Risk Factors</article-title>. <source>Eur. J. Prev. Cardiol.</source> <volume>1</volume>, <fpage>1</fpage>. <pub-id pub-id-type="doi">10.1177/2047487320926780</pub-id> </citation>
</ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shin</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Saeed</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Esch</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Guariento</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Blitzer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Moskowitzova</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>A Novel Biological Strategy for Myocardial Protection by Intracoronary Delivery of Mitochondria: Safety and Efficacy</article-title>. <source>JACC Basic Transl. Sci.</source> <volume>4</volume> (<issue>8</issue>), <fpage>871</fpage>&#x2013;<lpage>888</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacbts.2019.08.007</pub-id> </citation>
</ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shoji</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sumi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kusunoki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Uba</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Matsuo</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Pharmacological Polysulfide Suppresses Glucose-Stimulated Insulin Secretion in an ATP-Sensitive Potassium Channel-dependent Manner</article-title>. <source>Sci. Rep.</source> <volume>9</volume> (<issue>1</issue>), <fpage>19377</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-55848-7</pub-id> </citation>
</ref>
<ref id="B94">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sim</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>D. K.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y. C.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>So</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>2002</year>). <article-title>ATP-sensitive K(&#x2b;) Channels Composed of Kir6.1 and SUR2B Subunits in guinea Pig Gastric Myocytes</article-title>. <source>Am. J. Physiol. Gastrointest. Liver Physiol.</source> <volume>282</volume> (<issue>1</issue>), <fpage>G137</fpage>&#x2013;<lpage>G144</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.00057x.2002</pub-id> </citation>
</ref>
<ref id="B95">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Small</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>McNeilly</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mary</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sheikh</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Delles</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Resistin Mediates Sex-dependent Effects of Perivascular Adipose Tissue on Vascular Function in the Shrsp</article-title>. <source>Sci. Rep.</source> <volume>9</volume> (<issue>1</issue>), <fpage>6897</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-43326-z</pub-id> </citation>
</ref>
<ref id="B96">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smeland</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>McClenaghan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Roessler</surname>
<given-names>H. I.</given-names>
</name>
<name>
<surname>Savelberg</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>G. &#xc5;. M.</given-names>
</name>
<name>
<surname>Hjellnes</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>ABCC9-related Intellectual Disability Myopathy Syndrome Is a KATP Channelopathy with Loss-Of-Function Mutations in ABCC9</article-title>. <source>Nat. Commun.</source> <volume>10</volume> (<issue>1</issue>), <fpage>4457</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-12428-7</pub-id> </citation>
</ref>
<ref id="B97">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Neill</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hoiland</surname>
<given-names>R. L.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Scratching the Surface of Hypoxic Cerebral Vascular Control: a Potentially Polarizing View of Mechanistic Research in Humans</article-title>. <source>J. Physiol.</source> <volume>598</volume> (<issue>16</issue>), <fpage>3313</fpage>&#x2013;<lpage>3315</lpage>. <pub-id pub-id-type="doi">10.1113/JP280244</pub-id> </citation>
</ref>
<ref id="B98">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Solhjoo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>O&#x27;Rourke</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Mitochondrial Instability during Regional Ischemia-Reperfusion Underlies Arrhythmias in Monolayers of Cardiomyocytes</article-title>. <source>J. Mol. Cell Cardiol.</source> <volume>78</volume>, <fpage>90</fpage>&#x2013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2014.09.024</pub-id> </citation>
</ref>
<ref id="B99">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sooklal</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>L&#xf3;pez-Alonso</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Papp</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kanelis</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Phosphorylation Alters the Residual Structure and Interactions of the Regulatory L1 Linker Connecting NBD1 to the Membrane-Bound Domain in SUR2B</article-title>. <source>Biochemistry</source> <volume>57</volume> (<issue>44</issue>), <fpage>6278</fpage>&#x2013;<lpage>6292</lpage>. <pub-id pub-id-type="doi">10.1021/acs.biochem.8b00503</pub-id> </citation>
</ref>
<ref id="B100">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stewart</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>N. A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Channelling the Force to Reprogram the Matrix: Mechanosensitive Ion Channels in Cardiac Fibroblasts</article-title>. <source>Cells</source> <volume>10</volume> (<issue>5</issue>), <fpage>990</fpage>. <pub-id pub-id-type="doi">10.3390/cells10050990</pub-id> </citation>
</ref>
<ref id="B101">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sudhir</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Sukhodub</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jovanovi&#x107;</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jovanovi&#x107;</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Improved Adaptation to Physical Stress in Mice Overexpressing SUR2A Is Associated with Changes in the Pattern of Q-T Interval</article-title>. <source>Pflugers Arch.</source> <volume>472</volume> (<issue>6</issue>), <fpage>683</fpage>&#x2013;<lpage>691</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-020-02401-5</pub-id> </citation>
</ref>
<ref id="B102">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Svalastoga</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sulen</surname>
<given-names>&#xc5;.</given-names>
</name>
<name>
<surname>Fehn</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Aukland</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Irgens</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sirnes</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Intellectual Disability in KATP Channel Neonatal Diabetes</article-title>. <source>Diabetes Care</source> <volume>43</volume> (<issue>3</issue>), <fpage>526</fpage>&#x2013;<lpage>533</lpage>. <pub-id pub-id-type="doi">10.2337/dc19-1013</pub-id> </citation>
</ref>
<ref id="B103">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takasawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Miyakawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Adachi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Shidei</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sutani</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Marked Clinical Heterogeneity in Congenital Hyperinsulinism Due to a Novel Homozygous ABCC8 Mutation</article-title>. <source>Clin. Endocrinol. (Oxf)</source> <volume>94</volume> (<issue>6</issue>), <fpage>940</fpage>&#x2013;<lpage>948</lpage>. <pub-id pub-id-type="doi">10.1111/cen.14443</pub-id> </citation>
</ref>
<ref id="B104">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Testai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sestito</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Martelli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gorica</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Flori</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Calderone</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Synthesis and Pharmacological Characterization of Mitochondrial KATP Channel Openers with Enhanced Mitochondriotropic Effects</article-title>. <source>Bioorg Chem.</source> <volume>107</volume>, <fpage>104572</fpage>. <pub-id pub-id-type="doi">10.1016/j.bioorg.2020.104572</pub-id> </citation>
</ref>
<ref id="B105">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Udelson</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>G. D.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Zile</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Redfield</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Burnett</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients with Heart Failure with Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical Trial</article-title>. <source>JAMA</source> <volume>324</volume> (<issue>15</issue>), <fpage>1522</fpage>&#x2013;<lpage>1531</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2020.16641</pub-id> </citation>
</ref>
<ref id="B106">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Usher</surname>
<given-names>S. G.</given-names>
</name>
<name>
<surname>Ashcroft</surname>
<given-names>F. M.</given-names>
</name>
<name>
<surname>Puljung</surname>
<given-names>M. C.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Nucleotide Inhibition of the Pancreatic ATP-Sensitive K&#x2b; Channel Explored with Patch-Clamp Fluorometry</article-title>. <source>Elife</source> <volume>9</volume>, <fpage>e52775</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.52775</pub-id> </citation>
</ref>
<ref id="B107">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>White Mulberry Fruit Polysaccharides Enhance Endothelial Nitric Oxide Production to Relax Arteries <italic>In Vitro</italic> and Reduce Blood Pressure <italic>In Vivo</italic>
</article-title>. <source>Biomed. Pharmacother.</source> <volume>116</volume>, <fpage>109022</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2019.109022</pub-id> </citation>
</ref>
<ref id="B108">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Advances in the Mechanism and Treatment of Mitochondrial Quality Control Involved in Myocardial Infarction</article-title>. <source>J. Cell Mol. Med.</source> <volume>25</volume> (<issue>15</issue>), <fpage>7110</fpage>&#x2013;<lpage>7121</lpage>. <pub-id pub-id-type="doi">10.1111/jcmm.16744</pub-id> </citation>
</ref>
<ref id="B109">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y. F.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>SUR2B/Kir6.1 Channel Openers Correct Endothelial Dysfunction in Chronic Heart Failure via the miR-1-3p/ET-1 Pathway</article-title>. <source>Biomed. Pharmacother.</source> <volume>110</volume>, <fpage>431</fpage>&#x2013;<lpage>439</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2018.11.135</pub-id> </citation>
</ref>
<ref id="B110">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>W. L.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>T. Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y. Z.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Advances in the Protective Mechanism of NO, H2S, and H2 in Myocardial Ischemic Injury</article-title>. <source>Front. Cardiovasc Med.</source> <volume>7</volume>, <fpage>588206</fpage>. <pub-id pub-id-type="doi">10.3389/fcvm.2020.588206</pub-id> </citation>
</ref>
<ref id="B111">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>White</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Chowdhury</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Idikuda</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Retterer</surname>
<given-names>S. T.</given-names>
</name>
<name>
<surname>Goldsmith</surname>
<given-names>R. H.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>cAMP Binding to Closed Pacemaker Ion Channels Is Non-cooperative</article-title>. <source>Nature</source> <volume>595</volume> (<issue>7868</issue>), <fpage>606</fpage>&#x2013;<lpage>610</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-021-03686-x</pub-id> </citation>
</ref>
<ref id="B112">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>H. Q.</given-names>
</name>
<name>
<surname>Jana</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Rindler</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Coetzee</surname>
<given-names>W. A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The Trafficking Protein, EHD2, Positively Regulates Cardiac Sarcolemmal KATP Channel Surface Expression: Role in Cardioprotection</article-title>. <source>FASEB J.</source> <volume>32</volume> (<issue>3</issue>), <fpage>1613</fpage>&#x2013;<lpage>1625</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201700027R</pub-id> </citation>
</ref>
<ref id="B113">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>H. Q.</given-names>
</name>
<name>
<surname>Martinez-Ortiz</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cardozo</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Coetzee</surname>
<given-names>W. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Palmitoylation of the KATP Channel Kir6.2 Subunit Promotes Channel Opening by Regulating PIP2 Sensitivity</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>117</volume> (<issue>19</issue>), <fpage>10593</fpage>&#x2013;<lpage>10602</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1918088117</pub-id> </citation>
</ref>
<ref id="B114">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y. C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L. P.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y. B.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Transcriptional Regulation of Intermolecular Ca2&#x2b; Signaling in Hibernating Ground Squirrel Cardiomyocytes: The Myocardin-Junctophilin axis</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>118</volume> (<issue>14</issue>), <fpage>e2025333118</fpage>. <pub-id pub-id-type="doi">10.1073/pnas.2025333118</pub-id> </citation>
</ref>
<ref id="B115">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dart</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kamishima</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Quayle</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Hypoxia and Metabolic Inhibitors Alter the Intracellular ATP:ADP Ratio and Membrane Potential in Human Coronary Artery Smooth Muscle Cells</article-title>. <source>PeerJ</source> <volume>8</volume>, <fpage>e10344</fpage>. <pub-id pub-id-type="doi">10.7717/peerj.10344</pub-id> </citation>
</ref>
<ref id="B116">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Geng</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>LARP7 Protects against Heart Failure by Enhancing Mitochondrial Biogenesis</article-title>. <source>Circulation</source> <volume>143</volume> (<issue>20</issue>), <fpage>2007</fpage>&#x2013;<lpage>2022</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.120.050812</pub-id> </citation>
</ref>
<ref id="B117">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>G.-J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S. H.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Hypoxia Augments NaHS-Induced ANP Secretion via KATP Channel, HIF-1&#x3b1; and PPAR-&#x3b3; Pathway</article-title>. <source>Peptides</source> <volume>121</volume>, <fpage>170123</fpage>. <pub-id pub-id-type="doi">10.1016/j.peptides.2019.170123</pub-id> </citation>
</ref>
<ref id="B118">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y. F.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Functional Modulation of Sarcolemmal KATP Channels by Atrial Natriuretic Peptide-Elicited Intracellular Signaling in Adult Rabbit Ventricular Cardiomyocytes</article-title>. <source>Am. J. Physiol. Cell Physiol.</source> <volume>319</volume> (<issue>1</issue>), <fpage>C194</fpage>&#x2013;<lpage>C207</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00409.2019</pub-id> </citation>
</ref>
<ref id="B119">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>de Almeida</surname>
<given-names>T. S.</given-names>
</name>
<name>
<surname>Emfinger</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>McClenaghan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Harter</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Complex Consequences of Cantu Syndrome SUR2 Variant R1154Q in Genetically Modified Mice</article-title>. <source>JCI Insight</source> <volume>6</volume> (<issue>5</issue>), <fpage>e145934</fpage>. <pub-id pub-id-type="doi">10.1172/jci.insight.145934</pub-id> </citation>
</ref>
<ref id="B120">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H. X.</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y. W.</given-names>
</name>
<name>
<surname>Verbsky</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>U. S.</given-names>
</name>
<name>
<surname>Kanter</surname>
<given-names>E. M.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Heterogeneity and Function of K(ATP) Channels in Canine Hearts</article-title>. <source>Heart rhythm.</source> <volume>10</volume> (<issue>10</issue>), <fpage>1576</fpage>&#x2013;<lpage>1583</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2013.07.020</pub-id> </citation>
</ref>
<ref id="B121">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Sarcolemmal ATP-Sensitive Potassium Channel Protects Cardiac Myocytes against Lipopolysaccharide-Induced Apoptosis</article-title>. <source>Int. J. Mol. Med.</source> <volume>38</volume> (<issue>3</issue>), <fpage>758</fpage>&#x2013;<lpage>766</lpage>. <pub-id pub-id-type="doi">10.3892/ijmm.2016.2664</pub-id> </citation>
</ref>
<ref id="B122">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>The Effectiveness and Safety of Nicorandil in the Treatment of Patients with Microvascular Angina: A Protocol for Systematic Review and Meta-Analysis</article-title>. <source>Med. Baltim.</source> <volume>100</volume> (<issue>2</issue>), <fpage>e23888</fpage>. <pub-id pub-id-type="doi">10.1097/MD.0000000000023888</pub-id> </citation>
</ref>
<ref id="B123">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kaplan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Greiser</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lederer</surname>
<given-names>W. J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The Surprising Complexity of KATP Channel Biology and of Genetic Diseases</article-title>. <source>J. Clin. Invest</source> <volume>130</volume> (<issue>3</issue>), <fpage>1112</fpage>&#x2013;<lpage>1115</lpage>. <pub-id pub-id-type="doi">10.1172/JCI135759</pub-id> </citation>
</ref>
<ref id="B124">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Vasodilatory Effect of Formaldehyde via the NO/cGMP Pathway and the Regulation of Expression of KATP, BKCa and L-type Ca<sup>2&#x2b;</sup> Channels</article-title>. <source>Toxicol. Lett.</source> <volume>312</volume>, <fpage>55</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxlet.2019.04.006</pub-id> </citation>
</ref>
<ref id="B125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yoshikawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Akashi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Miura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T. S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Localization of ATP-Sensitive K&#x2b; Channel Subunits in Rat Liver</article-title>. <source>World J. Exp. Med.</source> <volume>9</volume> (<issue>2</issue>), <fpage>14</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.5493/wjem.v9.i2.14</pub-id> </citation>
</ref>
<ref id="B126">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Z. Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W. R.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>W. T.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Z. L.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>J. G.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Endothelial-Dependent and Independent Vascular Relaxation Effect of Tetrahydropalmatine on Rat Aorta</article-title>. <source>Front. Pharmacol.</source> <volume>10</volume>, <fpage>336</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2019.00336</pub-id> </citation>
</ref>
<ref id="B127">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Penehyclidine Hydrochloride Protects against Anoxia/reoxygenation Injury in Cardiomyocytes through ATP-Sensitive Potassium Channels, and the Akt/GSK-3&#x3b2; and Akt/mTOR Signaling Pathways</article-title>. <source>Cell Biol. Int.</source> <volume>44</volume> (<issue>6</issue>), <fpage>1353</fpage>&#x2013;<lpage>1362</lpage>. <pub-id pub-id-type="doi">10.1002/cbin.11329</pub-id> </citation>
</ref>
</ref-list>
<sec id="s11">
<title>Glossary</title>
<def-list>
<def-item>
<term id="G1-fphar.2022.868401">
<bold>ADP</bold>
</term>
<def>
<p>adenosine diphosphate</p>
</def>
</def-item>
<def-item>
<term id="G2-fphar.2022.868401">
<bold>AIMS</bold>
</term>
<def>
<p>ABCC9-related intellectual disability myopathy Syndrome</p>
</def>
</def-item>
<def-item>
<term id="G3-fphar.2022.868401">
<bold>ANP</bold>
</term>
<def>
<p>atrial natriuretic peptide</p>
</def>
</def-item>
<def-item>
<term id="G4-fphar.2022.868401">
<bold>ANT</bold>
</term>
<def>
<p>adenine nucleotide translocator</p>
</def>
</def-item>
<def-item>
<term id="G5-fphar.2022.868401">
<bold>AP</bold>
</term>
<def>
<p>action potential</p>
</def>
</def-item>
<def-item>
<term id="G6-fphar.2022.868401">
<bold>APD</bold>
</term>
<def>
<p>action potential duration</p>
</def>
</def-item>
<def-item>
<term id="G7-fphar.2022.868401">
<bold>ATP</bold>
</term>
<def>
<p>adenosine triphosphate</p>
</def>
</def-item>
<def-item>
<term id="G8-fphar.2022.868401">
<bold>BCL2</bold>
</term>
<def>
<p>B-cell lymphoma-2</p>
</def>
</def-item>
<def-item>
<term id="G9-fphar.2022.868401">
<bold>CaMK</bold>
</term>
<def>
<p>calcium/calmodulin-dependent protein kinase</p>
</def>
</def-item>
<def-item>
<term id="G10-fphar.2022.868401">
<bold>CF</bold>
</term>
<def>
<p>cardiac fibroblasts</p>
</def>
</def-item>
<def-item>
<term id="G11-fphar.2022.868401">
<bold>cGMP</bold>
</term>
<def>
<p>cyclic guanosine monophosphate</p>
</def>
</def-item>
<def-item>
<term id="G12-fphar.2022.868401">
<bold>CHI</bold>
</term>
<def>
<p>congenital hyperinsulinism</p>
</def>
</def-item>
<def-item>
<term id="G13-fphar.2022.868401">
<bold>CO</bold>
</term>
<def>
<p>carbon monoxide</p>
</def>
</def-item>
<def-item>
<term id="G14-fphar.2022.868401">
<bold>CORM-3</bold>
</term>
<def>
<p>CO-releasing molecule-3</p>
</def>
</def-item>
<def-item>
<term id="G15-fphar.2022.868401">
<bold>CS</bold>
</term>
<def>
<p>cant&#xfa; syndrome</p>
</def>
</def-item>
<def-item>
<term id="G16-fphar.2022.868401">
<bold>CSE</bold>
</term>
<def>
<p>cystathionine <italic>&#x3b3;</italic>-lyase</p>
</def>
</def-item>
<def-item>
<term id="G17-fphar.2022.868401">
<bold>Cyt C</bold>
</term>
<def>
<p>cytochrome C</p>
</def>
</def-item>
<def-item>
<term id="G18-fphar.2022.868401">
<bold>DEND syndrome</bold>
</term>
<def>
<p>developmental delay epilepsy and neonatal diabetes syndrome</p>
</def>
</def-item>
<def-item>
<term id="G19-fphar.2022.868401">
<bold>EAD</bold>
</term>
<def>
<p>early afterdepolarization</p>
</def>
</def-item>
<def-item>
<term id="G20-fphar.2022.868401">
<bold>EHD-2</bold>
</term>
<def>
<p>Eps15 homology domain-containing protein-2</p>
</def>
</def-item>
<def-item>
<term id="G21-fphar.2022.868401">
<bold>ERK</bold>
</term>
<def>
<p>extracellular signal-regulated protein kinase</p>
</def>
</def-item>
<def-item>
<term id="G22-fphar.2022.868401">
<bold>GST</bold>
</term>
<def>
<p>genistein</p>
</def>
</def-item>
<def-item>
<term id="G23-fphar.2022.868401">
<bold>H<sub>2</sub>S</bold>
</term>
<def>
<p>hydrogen sulfide</p>
</def>
</def-item>
<def-item>
<term id="G24-fphar.2022.868401">
<bold>HCN</bold>
</term>
<def>
<p>hyperpolarization-activated cyclic-nucleotide gated channels</p>
</def>
</def-item>
<def-item>
<term id="G25-fphar.2022.868401">
<bold>hESC</bold>
</term>
<def>
<p>human embryonic stem cell</p>
</def>
</def-item>
<def-item>
<term id="G26-fphar.2022.868401">
<bold>HF</bold>
</term>
<def>
<p>heart failure</p>
</def>
</def-item>
<def-item>
<term id="G27-fphar.2022.868401">
<bold>HO-1/CO</bold>
</term>
<def>
<p>heme oxygenase-1/carbon monoxide</p>
</def>
</def-item>
<def-item>
<term id="G29-fphar.2022.868401">
<bold>IMM</bold>
</term>
<def>
<p>inner mitochondrial membrane</p>
</def>
</def-item>
<def-item>
<term id="G30-fphar.2022.868401">
<bold>INS-1E cells</bold>
</term>
<def>
<p>a pancreatic <italic>&#xdf;</italic> cell line</p>
</def>
</def-item>
<def-item>
<term id="G31-fphar.2022.868401">
<bold>K<sup>&#x2b;</sup>
</bold>
</term>
<def>
<p>potassium</p>
</def>
</def-item>
<def-item>
<term id="G32-fphar.2022.868401">
<bold>KATP channels</bold>
</term>
<def>
<p>ATP-sensitive potassium channels;</p>
</def>
</def-item>
<def-item>
<term id="G33-fphar.2022.868401">
<bold>Kir</bold>
</term>
<def>
<p>K<sup>&#x2b;</sup> inward rectifiers</p>
</def>
</def-item>
<def-item>
<term id="G34-fphar.2022.868401">
<bold>LDL</bold>
</term>
<def>
<p>low-density lipoprotein</p>
</def>
</def-item>
<def-item>
<term id="G35-fphar.2022.868401">
<bold>LPS</bold>
</term>
<def>
<p>lipopolysaccharide</p>
</def>
</def-item>
<def-item>
<term id="G36-fphar.2022.868401">
<bold>MF</bold>
</term>
<def>
<p>myofibroblasts</p>
</def>
</def-item>
<def-item>
<term id="G37-fphar.2022.868401">
<bold>MIRI</bold>
</term>
<def>
<p>myocardial ischaemia reperfusion injury</p>
</def>
</def-item>
<def-item>
<term id="G38-fphar.2022.868401">
<bold>mitoKATP</bold>
</term>
<def>
<p>mitochondrial ATP-sensitive potassium</p>
</def>
</def-item>
<def-item>
<term id="G39-fphar.2022.868401">
<bold>MPTP</bold>
</term>
<def>
<p>permeability transition pore</p>
</def>
</def-item>
<def-item>
<term id="G41-fphar.2022.868401">
<bold>NBF</bold>
</term>
<def>
<p>nucleotide binding folds</p>
</def>
</def-item>
<def-item>
<term id="G42-fphar.2022.868401">
<bold>NDM</bold>
</term>
<def>
<p>neonatal diabetes mellitus</p>
</def>
</def-item>
<def-item>
<term id="G43-fphar.2022.868401">
<bold>NO</bold>
</term>
<def>
<p>nitric oxide</p>
</def>
</def-item>
<def-item>
<term id="G44-fphar.2022.868401">
<bold>NPR-A</bold>
</term>
<def>
<p>natriuretic peptide receptor type A</p>
</def>
</def-item>
<def-item>
<term id="G45-fphar.2022.868401">
<bold>O<sub>2</sub>
</bold>
</term>
<def>
<p>oxygen</p>
</def>
</def-item>
<def-item>
<term id="G46-fphar.2022.868401">
<bold>ONOO-</bold>
</term>
<def>
<p>peroxynitrite</p>
</def>
</def-item>
<def-item>
<term id="G47-fphar.2022.868401">
<bold>PCI</bold>
</term>
<def>
<p>percutaneous coronary intervention</p>
</def>
</def-item>
<def-item>
<term id="G48-fphar.2022.868401">
<bold>PHC</bold>
</term>
<def>
<p>penehyclidine hydrochloride</p>
</def>
</def-item>
<def-item>
<term id="G49-fphar.2022.868401">
<bold>PNDM</bold>
</term>
<def>
<p>permanent neonatal diabetes mellitus</p>
</def>
</def-item>
<def-item>
<term id="G50-fphar.2022.868401">
<bold>PiC</bold>
</term>
<def>
<p>phosphate carrier</p>
</def>
</def-item>
<def-item>
<term id="G51-fphar.2022.868401">
<bold>PKG</bold>
</term>
<def>
<p>cGMP-dependent protein kinase</p>
</def>
</def-item>
<def-item>
<term id="G52-fphar.2022.868401">
<bold>PLN</bold>
</term>
<def>
<p>phospholamban</p>
</def>
</def-item>
<def-item>
<term id="G53-fphar.2022.868401">
<bold>ROS</bold>
</term>
<def>
<p>reactive oxygen species</p>
</def>
</def-item>
<def-item>
<term id="G54-fphar.2022.868401">
<bold>RyR</bold>
</term>
<def>
<p>ryanodine receptor</p>
</def>
</def-item>
<def-item>
<term id="G55-fphar.2022.868401">
<bold>sarcKATP</bold>
</term>
<def>
<p>sarcolemma ATP-sensitive potassium</p>
</def>
</def-item>
<def-item>
<term id="G56-fphar.2022.868401">
<bold>SCD</bold>
</term>
<def>
<p>sudden cardiac death</p>
</def>
</def-item>
<def-item>
<term id="G57-fphar.2022.868401">
<bold>SO<sub>2</sub>
</bold>
</term>
<def>
<p>sulfur dioxide</p>
</def>
</def-item>
<def-item>
<term id="G58-fphar.2022.868401">
<bold>SUR</bold>
</term>
<def>
<p>sulfonylurea receptors</p>
</def>
</def-item>
<def-item>
<term id="G59-fphar.2022.868401">
<bold>TMD</bold>
</term>
<def>
<p>transmembrane domains</p>
</def>
</def-item>
<def-item>
<term id="G60-fphar.2022.868401">
<bold>TNDM</bold>
</term>
<def>
<p>transient neonatal diabetes mellitus</p>
</def>
</def-item>
<def-item>
<term id="G62-fphar.2022.868401">
<bold>VCMs</bold>
</term>
<def>
<p>ventricular cardiomyocytes</p>
</def>
</def-item>
<def-item>
<term id="G63-fphar.2022.868401">
<bold>ZFHX3</bold>
</term>
<def>
<p>zinc finger homeobox three gene</p>
</def>
</def-item>
</def-list>
</sec>
</back>
</article>